# EDGAR Filing Document

**Accession Number:** 0000913144
**File Stem:** 0000913144-26-000063
**Filing Date:** 2026-4
**Character Count:** 171502
**Document Hash:** 1323b9dd77f399ac8a70b4b99b1d6441
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000913144-26-000063.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0000913144-26-000063

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 17

**CONFORMED PERIOD OF REPORT**: 20260428

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RENAISSANCERE HOLDINGS LTD
- **CENTRAL INDEX KEY:** 0000913144
- **STANDARD INDUSTRIAL CLASSIFICATION:** FIRE, MARINE & CASUALTY INSURANCE [6331]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 980138020
- **STATE OF INCORPORATION:** D0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14428
- **FILM NUMBER:** 26908850

**BUSINESS ADDRESS:**
- **STREET 1:** RENAISSANCE HOUSE
- **STREET 2:** 12 CROW LANE
- **CITY:** PEMBROKE
- **STATE:** D0
- **ZIP:** HM19
- **BUSINESS PHONE:** 4412954513

**MAIL ADDRESS:**
- **STREET 1:** RENAISSANCE HOUSE
- **STREET 2:** 12 CROW LANE
- **CITY:** PEMBROKE
- **STATE:** D0
- **ZIP:** HM19

?xml version='1.0' encoding='ASCII'? rnr-20260428

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): April 28, 2026**

**RenaissanceRe Holdings Ltd.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Bermuda** | **001-14428** | **98-0141974** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

**Renaissance House, 12 Crow Lane, Pembroke, Bermuda &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HM 19** 

(Address of Principal Executive Office)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Zip Code)

**(441) 295-4513** 

(Registrant's telephone number, including area code)

**Not Applicable**

**(Former name or former address, if changed since last report).**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>symbol** | **Name of each exchange on which registered** |
| Common Shares, Par Value $1.00 per share | RNR | New York Stock Exchange |
| Depositary Shares, each representing a 1/1,000th interest in a Series F 5.750% Preference Share, Par Value $1.00 per share | RNR PRF | New York Stock Exchange |
| Depositary Shares, each representing a 1/1,000th interest in a Series G 4.20% Preference Share, Par Value $1.00 per share | RNR PRG | New York Stock Exchange |

---

------

**Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

On April 28, 2026, RenaissanceRe Holdings Ltd. (the "Company") issued a press release announcing its financial results for the first quarter ended March 31, 2026 and the availability of its corresponding financial supplement. Copies of the press release and the financial supplement are attached as Exhibit 99.1 and 99.2, respectively, to this Form 8-K. This Form 8-K and Exhibits 99.1 and 99.2 hereto are each being furnished to the Securities and Exchange Commission (the "SEC") pursuant to Item 2.02 of Form 8-K and are therefore not to be considered "filed" with the SEC.

**Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

(d) Exhibits.

**<u>Exhibit #</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Description</u>**

99.1\*&nbsp;&nbsp;&nbsp;&nbsp;<u>[Copy of the Company's press release, issued April 28, 2026.](rnrearningsrelease2026q1.htm)</u>

99.2\*&nbsp;&nbsp;&nbsp;&nbsp;<u>[Copy of the Company's Financial Supplement.](rnrfinancialsupplement2026.htm)</u>

104&nbsp;&nbsp;&nbsp;&nbsp;Cover Page Interactive Data File (embedded within the Inline XBRL document).

\* Exhibits 99.1 and 99.2 are being furnished to the SEC pursuant to Item 2.02 and are not being filed with the SEC. Therefore, these exhibits are not incorporated by reference in any of the registrant's other SEC filings.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | RENAISSANCERE HOLDINGS LTD. | RENAISSANCERE HOLDINGS LTD. |
| Date: | By: | /s/ Robert Qutub |
| April 28, 2026 |  | Robert Qutub |
|  |  | Executive Vice President and Chief Financial Officer |

---

## Exhibit 99.1

![rnrlogo_regmar25xmedresa.jpg](rnrlogo_regmar25xmedresa.jpg)

***RenaissanceRe Reports $284.5 Million of Quarterly Net Income Available to Common Shareholders and $590.5 Million of Operating Income Available to Common Shareholders in Q1 2026. Strong Performance Across All Three Drivers of Profit – Underwriting, Fee and Net Investment Income.***

***•*** 73.0% combined ratio.

**•** Fee income of $94.1 million, with strong contributions from management and performance fees.

**•** Net investment income of $420.5 million, up 3.7% from Q1 2025.

**•** Repurchased $352.5 million of common shares in Q1 2026. Repurchased an additional $104.8 million from April 1, 2026, through April 24, 2026.

• 10.5% annualized return on average common equity, including mark-to-market losses of $421.9 million, primarily from increased treasury yields and equity losses.

• 21.8% annualized operating return on average common equity.

**Pembroke, Bermuda, April 28, 2026** - RenaissanceRe Holdings Ltd. (NYSE: RNR) ("RenaissanceRe" or the "Company") today announced its financial results for the first quarter of 2026.

---

| | | |
|:---|:---|:---|
| **Net Income Available to Common Shareholders per Diluted Common Share: $6.57**<br>**Operating Income Available to Common Shareholders per Diluted Common Share: $13.75** | **Net Income Available to Common Shareholders per Diluted Common Share: $6.57**<br>**Operating Income Available to Common Shareholders per Diluted Common Share: $13.75** | **Net Income Available to Common Shareholders per Diluted Common Share: $6.57**<br>**Operating Income Available to Common Shareholders per Diluted Common Share: $13.75** |
| **Underwriting Income**<br>**$588.8M** | **Fee Income**<br>**$94.1M** | **Net Investment Income**<br>**$420.5M** |
| **Change in Book Value per Common Share: 1.4%**<br>**Change in Tangible Book Value per Common Share Plus Change in Accum. Dividends: 1.7%** | **Change in Book Value per Common Share: 1.4%**<br>**Change in Tangible Book Value per Common Share Plus Change in Accum. Dividends: 1.7%** | **Change in Book Value per Common Share: 1.4%**<br>**Change in Tangible Book Value per Common Share Plus Change in Accum. Dividends: 1.7%** |

---

*Operating Return on Average Common Equity, Operating Income (Loss) Available (Attributable) to Common Shareholders, Operating Income (Loss) Available (Attributable) to Common Shareholders per Diluted Common Share, Change in Tangible Book Value per Common Share Plus Change in Accumulated Dividends and Adjusted Combined Ratio are non-GAAP financial measures; see "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.*

**Kevin J. O'Donnell**, President and Chief Executive Officer, said, *"We started the year with a strong quarter, with significant contributions across each of our Three Drivers of Profit. We generated $284.5 million in net income available to common shareholders* and *$590.5 million in operating income available to common shareholders, and delivered an annualized return on average common equity of 10.5%* and *annualized operating return on average common equity of 21.8%. This strong performance was anchored by underwriting, where we delivered a low combined ratio of 73.0%, reflecting the strength of our underwriting decisions, deliberate portfolio construction and a disciplined reserving approach.*<br>*We continue to shape the underwriting portfolio to deliver superior returns for our shareholders. In a competitive, but still attractive environment, we successfully deployed additional limit into our highest margin business, property catastrophe.* <br>*Fee and investment income together contributed to a durable and diversified earnings base, with stable management fees, elevated performance fees, and investment income remaining near peak levels. During the quarter, we took advantage of investment market volatility to opportunistically reposition our investment portfolio, reducing our gold position, increasing allocations to investment-grade credit, and extending duration by half a year to further benefit from still attractive interest rate levels.*<br>*We also repurchased $352.5 million of shares during the quarter at an attractive premium to book value, reflecting our confidence in the intrinsic value of the franchise and our commitment to disciplined capital management. Taken together, these results reflect the strength and diversification of our platform and position us to continue compounding book value per common share over the long term."*<br>

------

**Consolidated Financial Results**<br>

---

| | | |
|:---|:---|:---|
| **Consolidated Highlights** | | |
|  | **Three months ended March 31,** | **Three months ended March 31,** |
| *(in thousands, except per share amounts and percentages)* | **2026** | **2025** |
| Gross premiums written | $3478873 | $4155503 |
| Net premiums written | 2678296 | 3443529 |
| Net premiums earned | 2183614 | 2720781 |
| Underwriting income (loss) | 588758 | (770597) |
| Combined ratio | 73.0% | 128.3% |
| Adjusted combined ratio <sup>(1)</sup> | 72.0% | 126.4% |
| **Net Income (Loss)** |  |  |
| &nbsp;&nbsp;&nbsp;Available (attributable) to common shareholders | 284535 | 161147 |
| &nbsp;&nbsp;&nbsp;Available (attributable) to common shareholders per diluted common share | $6.57 | $3.27 |
| &nbsp;&nbsp;&nbsp;Return on average common equity - annualized | 10.5% | 6.6% |
| **Operating Income (Loss)** <sup>(1)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;Available (attributable) to common shareholders <sup>(1)</sup> | 590537 | (69754) |
| &nbsp;&nbsp;&nbsp;Available (attributable) to common shareholders per diluted common share <sup>(1)</sup> | $13.75 | $(1.49) |
| &nbsp;&nbsp;&nbsp;Operating return on average common equity - annualized <sup>(1)</sup> | 21.8% | (2.9)% |
|  | **March 31,<br>2026** | **March 31,<br>2025** |
| **Book Value per Common Share** |  |  |
| &nbsp;&nbsp;&nbsp;Book value per common share | $250.48 | $196.18 |
| &nbsp;&nbsp;&nbsp;Quarterly change in book value per common share <sup>(2)</sup> | 1.4% | 0.2% |
| &nbsp;&nbsp;&nbsp;Quarterly change in book value per common share plus change in accumulated dividends <sup>(2)</sup> | 1.6% | 0.4% |
| **Tangible Book Value per Common Share** <sup>(1)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;Tangible book value per common share <sup>(1)</sup> | $233.49 | $178.31 |
| &nbsp;&nbsp;&nbsp;Tangible book value per common share plus accumulated dividends <sup>(1)</sup> | $263.58 | $206.79 |
| &nbsp;&nbsp;&nbsp;Quarterly change in tangible book value per common share plus change in accumulated dividends <sup>(1) (2)</sup> | 1.7% | 0.9% |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

(2)Represents the percentage change during the three months ended March 31, 2026, and March 31, 2025, respectively.

------

**Three Drivers of Profit: Underwriting, Fee and Investment Income**<br>

**Underwriting Results - Property Segment: Strong combined ratio of 34.1%, with lower catastrophe losses**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Property Segment** | | | | |
| | **Three months ended March 31,** | **Three months ended March 31,** | **Q/Q Change** | **Q/Q Change** |
| *(in thousands, except percentages)* | **2026** | **2025** | **Q/Q Change** | **Q/Q Change** |
| Gross premiums written | $1707420 | $2130833 | (19.9)% | (19.9)% |
| Net premiums written | 1255193 | 1690994 | (25.8)% | (25.8)% |
| Net premiums earned | 900738 | 1247950 | (27.8)% | (27.8)% |
| Underwriting income (loss) | 593863 | (607218) |  |  |
| **Underwriting Ratios** |  |  |  |  |
| Net claims and claim expense ratio - current accident year | 27.2% | 145.1% | (117.9) | pts |
| Net claims and claim expense ratio - prior accident years | (17.9)% | (15.0)% | (2.9) | pts |
| Net claims and claim expense ratio - calendar year | 9.3% | 130.1% | (120.8) | pts |
| Underwriting expense ratio | 24.8% | 18.6% | 6.2 | pts |
| Combined ratio | 34.1% | 148.7% | (114.6) | pts |
| Adjusted combined ratio <sup>(1)</sup> | 33.0% | 147.1% | (114.1) | pts |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

**• Gross premiums written** decreased by $423.4 million, or 19.9%, driven by:

–a decrease of $387.0 million, or 23.2%, in the catastrophe class, as:

–Q1 2025 included $338.4 million of reinstatement premiums, primarily related to the California wildfires; otherwise, not including reinstatement premiums, gross premiums written in the catastrophe class decreased by $42.8 million, or 3.2%, with rate reductions largely offset by other opportunities for growth.

–a decrease of $36.4 million in the other property class, primarily due to rate decreases in catastrophe-exposed business.

**• Net claims and claim expense ratio - current accident year** improved by 117.9 percentage points, due to:

–a comparatively lower impact from large losses in the quarter, as Q1 2025 included 117.2 percentage points from the California wildfires.

**• Net claims and claim expense ratio - prior accident years** reflected net favorable development of 17.9%, driven by:

–net favorable development of $62.6 million in the catastrophe class, primarily from the large loss events in 2021, 2022 and 2023; and

–net favorable development of $98.1 million in the other property class, primarily due to favorable attritional loss experience and net favorable development on the large loss events in 2024.

**• Underwriting expense ratio** increased by 6.2 percentage points, primarily driven by:

–the impact during Q1 2025 of net reinstatement premiums of $335.3 million, primarily from the California wildfires, which benefited the underwriting expense ratio by 6.8 percentage points in Q1 2025.

------

**• Combined ratio and adjusted combined ratio** each improved primarily due to the lower current accident year net losses.

**Underwriting Results - Casualty and Specialty Segment: Combined ratio of 100.4% and adjusted combined ratio of 99.4%, with lower impact from large losses compared to Q1 2025**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Casualty and Specialty Segment** | | | | |
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Q/Q Change** | **Q/Q Change** |
| *(in thousands, except percentages)* | **2026** | **2025** | **Q/Q Change** | **Q/Q Change** |
| Gross premiums written | $1771453 | $2024670 | (12.5)% | (12.5)% |
| Net premiums written | 1423103 | 1752535 | (18.8)% | (18.8)% |
| Net premiums earned | 1282876 | 1472831 | (12.9)% | (12.9)% |
| Underwriting income (loss) | (5105) | (163379) |  |  |
| **Underwriting Ratios** |  |  |  |  |
| Net claims and claim expense ratio - current accident year | 70.2% | 76.7% | (6.5) | pts |
| Net claims and claim expense ratio - prior accident years | (0.1)% | (0.6)% | 0.5 | pts |
| Net claims and claim expense ratio - calendar year | 70.1% | 76.1% | (6.0) | pts |
| Underwriting expense ratio | 30.3% | 35.0% | (4.7) | pts |
| Combined ratio | 100.4% | 111.1% | (10.7) | pts |
| Adjusted combined ratio <sup>(1)</sup> | 99.4% | 108.8% | (9.4) | pts |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

**• Gross premiums written** decreased by $253.2 million, or 12.5%, primarily driven by decreases in the general casualty and other specialty classes.

**• Net premiums written** decreased by $329.4 million, or 18.8%, consistent with the drivers for gross premiums written discussed above, in addition to an increase in the Company's retrocessional purchases.

**• Net claims and claim expense ratio - current accident year** improved by 6.5 percentage points compared to Q1 2025, principally driven by the lower impact of large loss events within the other specialty class.

**• Net claims and claim expense ratio - prior accident years** reflected net favorable development of 0.1%, and included an adverse impact of 0.4 percentage points from purchase accounting adjustments.

**• Underwriting expense ratio** improved by 4.7 percentage points, primarily driven by:

–a 4.0 percentage point decrease in the acquisition expense ratio, due to changes in variable commissions and a decrease in purchase accounting adjustments related to the Validus Acquisition.

**• Combined ratio** and **adjusted combined ratio** each improved due to the lower impact of large loss events reflected in the net claims and claim expense ratio - current accident year and the lower underwriting expense ratio.

------

**Fee Income: $94.1 million of fee income, with strong contributions from management and performance fees**

---

| | | | |
|:---|:---|:---|:---|
| **Fee Income** | | | |
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Q/Q Change** |
| *(in thousands)* | **2026** | **2025** | **Q/Q Change** |
| Management fee income | $47927 | $46061 | $1866 |
| Performance fee income (loss) <sup>(1)</sup> | 46199 | (15604) | 61803 |
| Total fee income | $94126 | $30457 | $63669 |

---

(1)Performance fees are based on the performance of the individual vehicles or products and may be zero or negative in a particular period. For example, large losses could potentially result in no performance fees or the reversal of previously accrued performance fees.

**• Performance fee income** increased due to strong current year underwriting results, the recognition of deferred performance fees related to a return of capital in DaVinci, and higher prior accident years net favorable development within DaVinci.

**• Total fee income** in Q1 2026 included $72.2 million of fee income recorded in net income (loss) attributable to redeemable noncontrolling interests, which is not included in the Company's underwriting income (loss).

**Investment Results: Net investment income of $420.5 million, up 3.7% from Q1 2025; net realized and unrealized losses of $421.9 million, primarily from increased treasury yields and equity losses**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Investment Results** | | | | |
|  | **Three months ended March 31,** | **Three months ended March 31,** | **Q/Q Change** | **Q/Q Change** |
| *(in thousands, except percentages)* | **2026** | **2025** | **Q/Q Change** | **Q/Q Change** |
| Net investment income | $420502 | $405353 | $15149 | 15149 |
| Equity in earnings (losses) of other ventures | 20485 | 17828 | 2657 | 2657 |
| Net realized and unrealized gains (losses) on investments | (421913) | 332940 | (754853) | (754853) |
| Total investment result | $19074 | $756121 | $(737047) | (737047) |
| Net investment income return - annualized | 4.9% | 5.1% | (0.2) | pts |
| Total investment return - annualized | 0.3% | 9.6% | (9.3) | pts |

---

**• Net investment income** increased by $15.1 million, primarily due to higher average invested assets and portfolio reallocation, resulting in increased income from fixed maturity investments trading and fixed income exchange traded funds.

**• Net realized and unrealized losses on investments** in Q1 2026 were driven by:

–$267.9 million of net losses on fixed maturity-related investments, primarily due to increases in market yields in the quarter;

–$147.4 million of net losses on equity-related investments, primarily due to broader equity market declines;

–$60.4 million of net unrealized losses on direct private equity investments, driven by a decrease in the value of certain of the investments in the Company's strategic investments portfolio; offset by

–$65.3 million of net gains on commodity-related investments, principally due to realized gains on the sale of a portion of the Company's gold futures.

**• Total investments** were $35.2 billion at March 31, 2026 (December 31, 2025 - $36.1 billion). The weighted average yield to maturity and duration on the Company's investment portfolio (excluding investments that have no final maturity, yield to maturity or duration) was 5.1% and 2.9 years, respectively (December 31, 2025 - 4.8% and 2.6 years, respectively).

------

**Other Items of Note** <br>

**• Net income attributable to redeemable noncontrolling interests** of $222.5 million was primarily driven by:

–strong underwriting income in DaVinci and Vermeer; and

–$116.4 million of net investment income in the investment portfolios of the Company's joint ventures and managed funds; partially offset by

–$65.2 million of net realized and unrealized losses in the investment portfolios of the Company's joint ventures and managed funds; and

–$72.2 million of management and performance fee income.

**• Raised third party capital** of $61.4 million, including $46.0 million in Medici and $15.4 million in Medici UCITS.

**• Returned third party capital** of $930.3 million, including:

–$729.5 million to investors in DaVinci, Vermeer and Top Layer through share repurchases and dividends following strong earnings across these vehicles in 2025; and

–redemptions from certain third-party investors rebalancing their portfolios, primarily because of the strong results noted above.

**• Income tax expense** of $33.0 million in Q1 2026, compared to a benefit of $45.5 million in Q1 2025. The income tax expense was primarily driven by strong operating profits, partially offset by mark-to-market losses.

**• Operational and corporate expenses** decreased in Q1 2026, primarily driven by Bermuda tax credits and partially offset by an increase in compensation expenses.

**• Share repurchases** of 1.2 million common shares at an aggregate cost of $352.5 million and an average price of $289.36 per common share. Repurchased an additional $104.8 million from April 1, 2026, through April 24, 2026.

------

**Conference Call Details and Additional Information**<br>

**Non-GAAP Financial Measures and Additional Financial Information**

This Press Release includes certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP") including "operating income (loss) available (attributable) to RenaissanceRe common shareholders," "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted," "operating return on average common equity - annualized," "tangible book value per common share," "tangible book value per common share plus accumulated dividends," and "adjusted combined ratio." A reconciliation of such measures to the most comparable GAAP figures in accordance with Regulation G is presented in the attached supplemental financial data.

Please refer to the "Investors - Reports & Filings" section of the Company's website at <u>www.renre.com</u> for a copy of the Financial Supplement which includes additional information on the Company's financial performance.

**Conference Call Information**

RenaissanceRe will host a conference call on April 29, 2026, at 11:00 a.m. ET to discuss this release. A live webcast of the conference call will be available through the Investors section of RenaissanceRe's website at <u>investor.renre.com</u>. A replay will be available after the call at the same location.

**About RenaissanceRe**

RenaissanceRe is a global provider of reinsurance and insurance that specializes in matching desirable risk with efficient capital. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. Established in 1993, and headquartered in Bermuda, RenaissanceRe has offices across North America, Europe, and the Asia-Pacific region.

**Cautionary Statement Regarding Forward-Looking Statements**

Any forward-looking statements made in this Press Release reflect RenaissanceRe's current views with respect to future events and financial performance and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company may also make forward-looking statements with respect to its business and industry, such as those relating to its strategy and management objectives, plans and expectations regarding its response and ability to adapt to changing economic conditions, market standing and product volumes, estimates of net negative impact and insured losses from loss events, competition in the industry and government initiatives and regulatory matters affecting the (re)insurance industries. The inclusion of forward-looking statements in this report should not be considered as a representation by the Company that its current objectives or plans will be achieved. Numerous factors could cause the Company's actual results to differ materially from those addressed by the forward-looking statements, including the following: the Company's exposure to natural and non-natural catastrophic events and circumstances and the variance they may cause in the Company's financial results; the effect of climate change on the Company's business, including the trend towards increasingly frequent and severe climate events; the effectiveness of the Company's claims and claim expense reserving process; the effect of emerging claims and coverage issues; the performance of the Company's investment portfolio and financial market volatility; the effects of inflation; the Company's exposure to ceding companies and delegated authority counterparties and the risks they underwrite; the Company's ability to maintain its financial strength ratings; the Company's reliance on a small number of brokers; the highly competitive nature of the Company's industry; the historically cyclical nature of the (re)insurance industries; collection on claimed retrocessional coverage and new retrocessional reinsurance being available; the Company's ability to attract and retain key executives and employees; the Company's ability to successfully implement its business strategies and initiatives; the Company's exposure to credit loss from counterparties; the Company's need to make many estimates and judgments

------

in the preparation of its financial statements; the Company's exposure to risks associated with its management of capital on behalf of investors; changes to the accounting rules and regulatory systems applicable to the Company's business, including changes in Bermuda and U.S. laws or regulations; the effect of current or future macroeconomic or geopolitical events or trends, including the ongoing conflicts globally; other political, regulatory or industry initiatives adversely impacting the Company; the impact of cybersecurity risks, including technology breaches or failure; the Company's ability to comply with covenants in its debt agreements; the effect of adverse economic factors, including changes in the prevailing interest rates; the effects of new or possible future tax actions or reform legislation and regulations in the jurisdictions in which the Company operates; the Company's ability to determine any impairments taken on its investments; the Company's ability to raise capital on acceptable terms; the Company's ability to comply with applicable sanctions and foreign corrupt practices laws; the Company's dependence on capital distributions from its operating subsidiaries; and other factors affecting future results disclosed in RenaissanceRe's filings with the SEC, including its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.

---

| | |
|:---|:---|
| **INVESTOR CONTACT:**<br>RenaissanceRe Holdings Ltd.<br>Keith McCue<br>Senior Vice President, Finance & Investor Relations<br>(441) 239-4830 | **MEDIA CONTACT:**<br>RenaissanceRe Holdings Ltd.<br>Hayden Kenny<br>Senior Vice President, Investor Relations & Communications<br>(441) 239-4946<br>or<br>Kekst CNC<br>Nicholas Capuano<br>(917) 842-7859 |

---

------

---

| | | |
|:---|:---|:---|
| **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** |
| **Summary Consolidated Statements of Operations and Financial Data** | **Summary Consolidated Statements of Operations and Financial Data** | **Summary Consolidated Statements of Operations and Financial Data** |
| (in thousands of United States Dollars, except per share amounts and percentages) | (in thousands of United States Dollars, except per share amounts and percentages) | (in thousands of United States Dollars, except per share amounts and percentages) |
| (Unaudited) | (Unaudited) | (Unaudited) |
|  | **Three months ended** | **Three months ended** |
|  | **March 31,<br>2026** | **March 31,<br>2025** |
| **Revenues** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross premiums written | $3478873 | $4155503 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net premiums written | $2678296 | $3443529 |
| &nbsp;&nbsp;&nbsp;&nbsp;Decrease (increase) in unearned premiums | (494682) | (722748) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net premiums earned | 2183614 | 2720781 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 420502 | 405353 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange gains (losses) | (9019) | (7328) |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in earnings (losses) of other ventures | 20485 | 17828 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (loss) | 1247 | 914 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) on investments | (421913) | 332940 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total revenues*** | 2194916 | 3470488 |
| **Expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net claims and claim expenses incurred | 983971 | 2743758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition expenses | 521850 | 647435 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operational expenses | 89035 | 100185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate expenses | 19460 | 22810 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 31786 | 27086 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total expenses*** | 1646102 | 3541274 |
| Income (loss) before taxes | 548814 | (70786) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit (expense) | (32984) | 45525 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Net income (loss)*** | 515830 | (25261) |
| Net (income) loss attributable to redeemable noncontrolling interests | (222451) | 195252 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Net income (loss) attributable to RenaissanceRe*** | 293379 | 169991 |
| Dividends on preference shares | (8844) | (8844) |
| &nbsp;&nbsp;&nbsp;&nbsp;***Net income (loss) available (attributable) to RenaissanceRe common shareholders*** | $284535 | $161147 |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – basic | $6.60 | $3.29 |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted | $6.57 | $3.27 |
| Operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted <sup>(1)</sup> | $13.75 | $(1.49) |
| Average shares outstanding - basic | 42434 | 48334 |
| Average shares outstanding - diluted | 42628 | 48514 |
| Net claims and claim expense ratio | 45.1% | 100.8% |
| Underwriting expense ratio | 27.9% | 27.5% |
| Combined ratio | 73.0% | 128.3% |
| Return on average common equity - annualized | 10.5% | 6.6% |
| Operating return on average common equity - annualized <sup>(1)</sup> | 21.8% | (2.9)% |

---

(1)See Comments on Non-GAAP Financial Measures for a reconciliation of non-GAAP financial measures.

------

---

| | | |
|:---|:---|:---|
| **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** |
| **Summary Consolidated Balance Sheets** | **Summary Consolidated Balance Sheets** | **Summary Consolidated Balance Sheets** |
| (in thousands of United States Dollars, except per share amounts) | (in thousands of United States Dollars, except per share amounts) | (in thousands of United States Dollars, except per share amounts) |
|  | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets** |  |  |
| Fixed maturity investments trading, at fair value | $24901291 | $24884323 |
| Short-term investments, at fair value | 3883610 | 4759811 |
| Equity investments, at fair value | 1594284 | 1732990 |
| Other investments, at fair value | 4651495 | 4574214 |
| Investments in other ventures, under equity method | 140853 | 121871 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | 35171533 | 36073209 |
| Cash and cash equivalents | 1562883 | 1731181 |
| Premiums receivable | 8097885 | 7252454 |
| Prepaid reinsurance premiums | 1354841 | 993781 |
| Reinsurance recoverable | 3730957 | 3899913 |
| Accrued investment income | 234709 | 233688 |
| Deferred acquisition costs and value of business acquired | 1665666 | 1538540 |
| Deferred tax asset | 705661 | 701927 |
| Receivable for investments sold | 182534 | 414523 |
| Other assets | 393908 | 328087 |
| Goodwill and other intangible assets | 617772 | 633087 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total assets*** | $53718349 | $53800390 |
| **Liabilities, Noncontrolling Interests and Shareholders' Equity** |  |  |
| **Liabilities** |  |  |
| Reserve for claims and claim expenses | $22291058 | $22302345 |
| Unearned premiums | 6885462 | 6028174 |
| Debt | 2330051 | 2329201 |
| Reinsurance balances payable | 2821884 | 2540518 |
| Payable for investments purchased | 308635 | 533101 |
| Other liabilities | 523894 | 856302 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total liabilities*** | 35160984 | 34589641 |
| Redeemable noncontrolling interests | 7043124 | 7602092 |
| **Shareholders' Equity** |  |  |
| Preference shares | 750000 | 750000 |
| Common shares | 42974 | 43962 |
| Additional paid-in capital |  |  |
| Accumulated other comprehensive income (loss) | (12152) | (12626) |
| Retained earnings | 10733419 | 10827321 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total shareholders' equity attributable to RenaissanceRe*** | 11514241 | 11608657 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total liabilities, noncontrolling interests and shareholders' equity*** | $53718349 | $53800390 |
| **Book value per common share** | $250.48 | $247.00 |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** |
| **Supplemental Financial Data - Segment Information** | **Supplemental Financial Data - Segment Information** | **Supplemental Financial Data - Segment Information** | **Supplemental Financial Data - Segment Information** |
| (in thousands of United States Dollars, except percentages) | (in thousands of United States Dollars, except percentages) | (in thousands of United States Dollars, except percentages) | (in thousands of United States Dollars, except percentages) |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
|  | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** |
|  | **Property** | **Casualty and Specialty** | **Total** |
| Gross premiums written | $1707420 | $1771453 | $3478873 |
| Net premiums written | $1255193 | $1423103 | $2678296 |
| Net premiums earned | $900738 | $1282876 | $2183614 |
| Net claims and claim expenses incurred | 84108 | 899863 | 983971 |
| Acquisition expenses | 157031 | 364819 | 521850 |
| Operational expenses | 65736 | 23299 | 89035 |
| Underwriting income (loss) | $593863 | $(5105) | 588758 |
| Net investment income |  |  | 420502 |
| Net foreign exchange gains (losses) |  |  | (9019) |
| Equity in earnings (losses) of other ventures |  |  | 20485 |
| Other income (loss) |  |  | 1247 |
| Net realized and unrealized gains (losses) on investments |  |  | (421913) |
| Corporate expenses |  |  | (19460) |
| Interest expense |  |  | (31786) |
| Income (loss) before taxes |  |  | 548814 |
| Income tax benefit (expense) |  |  | (32984) |
| Net (income) loss attributable to redeemable noncontrolling interests |  |  | (222451) |
| Dividends on preference shares |  |  | (8844) |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders |  |  | $284535 |
| Net claims and claim expenses incurred – current accident year | $244849 | $901137 | $1145986 |
| Net claims and claim expenses incurred – prior accident years | (160741) | (1274) | (162015) |
| Net claims and claim expenses incurred – total | $84108 | $899863 | $983971 |
| Net claims and claim expense ratio – current accident year | 27.2% | 70.2% | 52.5% |
| Net claims and claim expense ratio – prior accident years | (17.9)% | (0.1)% | (7.4)% |
| Net claims and claim expense ratio – calendar year | 9.3% | 70.1% | 45.1% |
| Underwriting expense ratio | 24.8% | 30.3% | 27.9% |
| Combined ratio | 34.1% | 100.4% | 73.0% |
|  | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** |
|  | **Property** | **Casualty and Specialty** | **Total** |
| Gross premiums written | $2130833 | $2024670 | $4155503 |
| Net premiums written | $1690994 | $1752535 | $3443529 |
| Net premiums earned | $1247950 | $1472831 | $2720781 |
| Net claims and claim expenses incurred | 1623257 | 1120501 | 2743758 |
| Acquisition expenses | 167645 | 479790 | 647435 |
| Operational expenses | 64266 | 35919 | 100185 |
| Underwriting income (loss) | $(607218) | $(163379) | (770597) |
| Net investment income |  |  | 405353 |
| Net foreign exchange gains (losses) |  |  | (7328) |
| Equity in earnings (losses) of other ventures |  |  | 17828 |
| Other income (loss) |  |  | 914 |
| Net realized and unrealized gains (losses) on investments |  |  | 332940 |
| Corporate expenses |  |  | (22810) |
| Interest expense |  |  | (27086) |
| Income (loss) before taxes |  |  | (70786) |
| Income tax benefit (expense) |  |  | 45525 |
| Net (income) loss attributable to redeemable noncontrolling interests |  |  | 195252 |
| Dividends on preference shares |  |  | (8844) |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders |  |  | $161147 |
| Net claims and claim expenses incurred – current accident year | $1810315 | $1129317 | $2939632 |
| Net claims and claim expenses incurred – prior accident years | (187058) | (8816) | (195874) |
| Net claims and claim expenses incurred – total | $1623257 | $1120501 | $2743758 |
| Net claims and claim expense ratio – current accident year | 145.1% | 76.7% | 108.0% |
| Net claims and claim expense ratio – prior accident years | (15.0)% | (0.6)% | (7.2)% |
| Net claims and claim expense ratio – calendar year | 130.1% | 76.1% | 100.8% |
| Underwriting expense ratio | 18.6% | 35.0% | 27.5% |
| Combined ratio | 148.7% | 111.1% | 128.3% |

---

------

---

| | | |
|:---|:---|:---|
| **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** |
| **Supplemental Financial Data - Gross Premiums Written** | **Supplemental Financial Data - Gross Premiums Written** | **Supplemental Financial Data - Gross Premiums Written** |
| (in thousands of United States Dollars) | (in thousands of United States Dollars) | (in thousands of United States Dollars) |
| (Unaudited) | (Unaudited) | (Unaudited) |
|  | **Three months ended** | **Three months ended** |
|  | **March 31,<br>2026** | **March 31,<br>2025** |
| **<u>Property Segment</u>** |  |  |
| Catastrophe | $1279607 | $1666641 |
| Other property | 427813 | 464192 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property segment gross premiums written | $1707420 | $2130833 |
| **<u>Casualty and Specialty Segment</u>** |  |  |
| General casualty <sup>(1)</sup> | $500958 | $680449 |
| Professional liability <sup>(2)</sup> | 299696 | 236961 |
| Credit <sup>(3)</sup> | 359304 | 400753 |
| Other specialty <sup>(4)</sup> | 611495 | 706507 |
| &nbsp;&nbsp;&nbsp;&nbsp;Casualty and Specialty segment gross premiums written | $1771453 | $2024670 |

---

(1)Includes automobile liability, casualty clash, employers' liability, umbrella or excess casualty, workers' compensation and general liability.

(2)Includes directors and officers, medical malpractice, professional indemnity and transactional liability.

(3)Includes financial guaranty, mortgage guaranty, political risk, surety and trade credit.

(4)Includes accident and health, agriculture, aviation, construction, cyber, energy, marine, satellite and terrorism. Lines of business such as regional multi-line and whole account may have characteristics of various other lines of business, and are allocated accordingly.

------

---

| | | |
|:---|:---|:---|
| **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** |
| **Supplemental Financial Data - Total Investment Result** | **Supplemental Financial Data - Total Investment Result** | **Supplemental Financial Data - Total Investment Result** |
| (in thousands of United States Dollars, except percentages) | (in thousands of United States Dollars, except percentages) | (in thousands of United States Dollars, except percentages) |
| (Unaudited) | (Unaudited) | (Unaudited) |
|  | **Three months ended** | **Three months ended** |
|  | **March 31,<br>2026** | **March 31,<br>2025** |
| **Net investment income** |  |  |
| &nbsp;&nbsp;&nbsp;Fixed maturity investments trading | $294494 | $284723 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 34306 | 41029 |
| &nbsp;&nbsp;&nbsp;Equity investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed income exchange traded funds | 21692 | 1184 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock <sup>(1)</sup> | 677 | 726 |
| &nbsp;&nbsp;&nbsp;Other investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Catastrophe bonds | 39932 | 54754 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fund and direct private equity investments <sup>(1)</sup> | 25211 | 18723 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 11163 | 11110 |
|  | 427475 | 412249 |
| &nbsp;&nbsp;&nbsp;Investment expenses | (6973) | (6896) |
| **Net investment income** | $420502 | $405353 |
| **Equity in earnings (losses) of other ventures** <sup>(2)</sup> | $20485 | $17828 |
| **Net realized and unrealized gains (losses) on investments** <sup>(3)</sup> |  |  |
| &nbsp;&nbsp;Fixed maturity-related investments <sup>(4)</sup> | $(267948) | $312877 |
| &nbsp;&nbsp;Equity-related investments <sup>(5)</sup> | (147426) | (49589) |
| &nbsp;&nbsp;Commodity-related investments <sup>(6)</sup> | 65310 | 117591 |
| &nbsp;&nbsp;Other investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Catastrophe bonds | (11829) | (40413) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fund and direct private equity investments <sup>(1)</sup> | (60020) | (7526) |
| **Net realized and unrealized gains (losses) on investments** | $(421913) | $332940 |
| **Total investment result** <sup>(2)</sup> | $19074 | $756121 |
| **Average invested assets** | $35622372 | $33116302 |
| **Net investment income return - annualized** | 4.9% | 5.1% |
| **Total investment return - annualized** <sup>(2)</sup> | 0.3% | 9.6% |

---

(1)In the fourth quarter of 2025, the Company revised the description of its "other equity investments" to "common stock" and its "other investments - other" to "other investments - fund and direct private equity investments."

(2)In the fourth quarter of 2025, the Company revised its presentation of "total investment result" and "total investment return - annualized" to include equity in earnings (losses) of other ventures. Comparative information for the prior periods presented have been updated to conform to the current presentation.

(3)In the fourth quarter of 2025, the Company revised its presentation of "net realized and unrealized gains (losses) on investments" to show amounts based on net investment exposure, which takes into account related derivative impacts. Comparative information for the prior periods have been updated to conform to the current presentation.

(4)Includes fixed maturity investments and investment-related derivatives, which includes interest rate futures, credit default swaps and interest rate swaps.

(5)Includes equity investments and investment-related derivatives, which includes equity futures and warrants.

(6)Includes commodity-related derivatives, which includes commodity futures and commodity options.

------

**Comments on Non-GAAP Financial Measures**

In addition to the GAAP financial measures set forth in this Press Release, the Company has included certain non-GAAP financial measures within the meaning of Regulation G. The Company has provided certain of these financial measures in previous investor communications and the Company's management believes that such measures are important to investors and other interested persons, and that investors and such other persons benefit from having a consistent basis for comparison between quarters and for comparison with other companies within or outside the industry. These measures may not, however, be comparable to similarly titled measures used by companies within or outside of the insurance industry. Investors are cautioned not to place undue reliance on these non-GAAP measures in assessing the Company's overall financial performance.

**Operating Income (Loss) Available (Attributable) to RenaissanceRe Common Shareholders, Operating Income (Loss) Available (Attributable) to RenaissanceRe Common Shareholders per Common Share – Diluted and Operating Return on Average Common Equity - Annualized**

The Company uses "operating income (loss) available (attributable) to RenaissanceRe common shareholders" as a measure to evaluate the underlying fundamentals of its operations and believes it to be a useful measure of its corporate performance. "Operating income (loss) available (attributable) to RenaissanceRe common shareholders" as used herein differs from "net income (loss) available (attributable) to RenaissanceRe common shareholders," which the Company believes is the most directly comparable GAAP measure, by the exclusion of (1) net realized and unrealized gains and losses on investments, excluding other investments - catastrophe bonds, (2) net foreign exchange gains and losses, (3) expenses or revenues associated with acquisitions, dispositions and impairments, (4) acquisition related purchase accounting adjustments, (5) the Bermuda net deferred tax benefit recorded prior to the January 1, 2025 effective date of the Bermuda corporate income tax and the Bermuda deferred tax benefit resulting from Bermuda law changes enacted in 2025, (6) the income tax expense or benefit associated with these adjustments, and (7) the portion of these adjustments attributable to the Company's redeemable noncontrolling interests. The Company also uses "operating income (loss) available (attributable) to RenaissanceRe common shareholders" to calculate "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted" and "operating return on average common equity - annualized."

The Company's management believes that "operating income (loss) available (attributable) to RenaissanceRe common shareholders," "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted" and "operating return on average common equity - annualized" are useful to management and investors because they provide for better comparability and more accurately measure the Company's results of operations and remove variability. Additionally, management believes that these measures provide a view of the Company's underlying business that allows for better comparisons of the Company's performance over time by focusing on the Company's core business operations.

The following table is a reconciliation of: (1) net income (loss) available (attributable) to RenaissanceRe common shareholders to "operating income (loss) available (attributable) to RenaissanceRe common shareholders"; (2) net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted to "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted"; and (3) return on average common equity - annualized to "operating return on average common equity - annualized."

------

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| (in thousands of United States Dollars, except per share amounts and percentages) | **March 31,<br>2026** | **March 31,<br>2025** |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders | $284535 | $161147 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds | 410084 | (373353) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange losses (gains) | 9019 | 7328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses (revenues) associated with acquisitions, dispositions and impairments | 3 | 1436 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related purchase accounting adjustments <sup>(1)</sup> | 22706 | 53571 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bermuda net deferred tax asset <sup>(2)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) <sup>(3)</sup> | (79743) | 39392 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to redeemable noncontrolling interests <sup>(4)</sup> | (56067) | 40725 |
| Operating income (loss) available (attributable) to RenaissanceRe common shareholders | $590537 | $(69754) |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted | $6.57 | $3.27 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds | 9.62 | (7.70) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange losses (gains) | 0.21 | 0.15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses (revenues) associated with acquisitions, dispositions and impairments |  | 0.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related purchase accounting adjustments <sup>(1)</sup> | 0.53 | 1.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bermuda net deferred tax asset <sup>(2)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) <sup>(3)</sup> | (1.86) | 0.81 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to redeemable noncontrolling interests <sup>(4)</sup> | (1.32) | 0.84 |
| Operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted | $13.75 | $(1.49) |
| Return on average common equity - annualized | 10.5% | 6.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds | 15.2% | (15.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange losses (gains) | 0.3% | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses (revenues) associated with acquisitions, dispositions and impairments | —% | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related purchase accounting adjustments <sup>(1)</sup> | 0.8% | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bermuda net deferred tax asset <sup>(2)</sup> | —% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) <sup>(3)</sup> | (2.9)% | 1.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to redeemable noncontrolling interests <sup>(4)</sup> | (2.1)% | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating return on average common equity - annualized | 21.8% | (2.9)% |

---

(1)Represents the purchase accounting adjustments related to the amortization of acquisition related intangible assets, amortization (accretion) of value of business acquired ("VOBA") and acquisition costs, and the fair value adjustments to the net reserves for claims and claim expenses for the three months ended March 31, 2026 for the acquisitions of Validus of $21.0 million (2025 - $50.7 million); and TMR and Platinum of $1.8 million (2025 - $2.9 million).

(2)Represents the net deferred tax benefit related to the 15% Bermuda corporate income tax recorded prior to the January 1, 2025 effective date and the deferred tax benefit related to Bermuda law changes enacted in 2025.

(3)Represents the income tax expense or benefit associated with the adjustments to net income (loss) available (attributable) to RenaissanceRe common shareholders. The income tax impact is estimated by applying the statutory income tax rates of applicable jurisdictions, adjusted for relevant factors and other applicable income taxes.

(4)Represents the portion of the adjustments above that are attributable to the Company's redeemable noncontrolling interests, including the income tax impact of those adjustments.

------

**Tangible Book Value Per Common Share and Tangible Book Value Per Common Share Plus Accumulated Dividends**

The Company has included in this Press Release "tangible book value per common share" and "tangible book value per common share plus accumulated dividends." "Tangible book value per common share" is defined as book value per common share excluding per share amounts for (1) acquisition related goodwill and other intangible assets, (2) other goodwill and intangible assets, and (3) acquisition related purchase accounting adjustments. "Tangible book value per common share plus accumulated dividends" is defined as book value per common share excluding per share amounts for (1) acquisition related goodwill and other intangible assets, (2) other goodwill and intangible assets, and (3) acquisition related purchase accounting adjustments, plus accumulated dividends.

The Company's management believes "tangible book value per common share" and "tangible book value per common share plus accumulated dividends" are useful to investors because they provide a more accurate measure of the realizable value of shareholder returns by excluding the impact of goodwill and intangible assets and acquisition related purchase accounting adjustments to provide for better comparability and a more accurate measure of the Company's underlying operations. The following table is a reconciliation of book value per common share to "tangible book value per common share" and "tangible book value per common share plus accumulated dividends."

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **March 31,<br>2025** |
| Book value per common share | $250.48 | $196.18 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related goodwill and other intangible assets <sup>(1)</sup> | (14.38) | (14.02) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other goodwill and intangible assets <sup>(2)</sup> | (0.20) | (0.19) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related purchase accounting adjustments <sup>(3)</sup> | (2.41) | (3.66) |
| Tangible book value per common share | 233.49 | 178.31 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for accumulated dividends | 30.09 | 28.48 |
| Tangible book value per common share plus accumulated dividends | $263.58 | $206.79 |
| Quarterly change in book value per common share <sup>(4)</sup> | 1.4% | 0.2% |
| Quarterly change in book value per common share plus change in accumulated dividends <sup>(4)</sup> | 1.6% | 0.4% |
| Quarterly change in tangible book value per common share plus change in accumulated dividends <sup>(4)</sup> | 1.7% | 0.9% |

---

(1)Represents the acquired goodwill and other intangible assets at March 31, 2026, of $617.8 million (2025 - $686.1 million) for the acquisitions of Validus of $392.9 million (2025 - $459.2 million), TMR of $24.7 million (2025 - $25.8 million) and Platinum of $200.1 million (2025 - $201.2 million).

(2)At March 31, 2026, the adjustment for other goodwill and intangible assets included $8.9 million (2025 - $8.9 million) of goodwill and other intangibles included in investments in other ventures, under equity method.

(3)Represents the purchase accounting adjustments related to the unamortized VOBA and acquisition costs, and the fair value adjustments to reserves at March 31, 2026 for the acquisitions of Validus of $61.9 million (2025 - $130.2 million), TMR of $42.2 million (2025 - $49.6 million) and Platinum of $(0.5) million (2025 - $(0.6) million). As of December 31, 2025, the purchase accounting adjustments related to the VOBA were fully amortized.

(4)Represents the percentage change during the three months ended March 31, 2026, and March 31, 2025, respectively.

------

**Adjusted Combined Ratio**

The Company has included in this Press Release "adjusted combined ratio" for the Company, its reportable segments and certain classes of business. "Adjusted combined ratio" is defined as the combined ratio adjusted for the impact of acquisition related purchase accounting, which includes the amortization of acquisition related intangible assets, purchase accounting adjustments related to the amortization (accretion) of VOBA and acquisition costs, and the fair value adjustments to the net reserve for claims and claim expenses for the acquisitions of Validus, TMR and Platinum. The combined ratio is calculated as the sum of (1) net claims and claim expenses incurred, (2) acquisition expenses, and (3) operational expenses; divided by net premiums earned. The acquisition related purchase accounting adjustments impact net claims and claim expenses incurred and acquisition expenses. The Company's management believes "adjusted combined ratio" is useful to management and investors because it provides for better comparability and more accurately measures the Company's underlying underwriting performance. The following table is a reconciliation of combined ratio to "adjusted combined ratio."

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** |
| | **Catastrophe** | **Other<br>Property** | **Property** | **Casualty and Specialty** | **Total** |
| Combined ratio | 20.4% | 56.8% | 34.1% | 100.4% | 73.0% |
| &nbsp;&nbsp;&nbsp;Adjustment for acquisition related purchase accounting adjustments <sup>(1)</sup> | (1.2)% | (0.7)% | (1.1)% | (1.0)% | (1.0)% |
| Adjusted combined ratio | 19.2% | 56.1% | 33.0% | 99.4% | 72.0% |
|  | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** |
|  | **Catastrophe** | **Other<br>Property** | **Property** | **Casualty and Specialty** | **Total** |
| Combined ratio | 175.6% | 83.6% | 148.7% | 111.1% | 128.3% |
| &nbsp;&nbsp;&nbsp;Adjustment for acquisition related purchase accounting adjustments <sup>(1)</sup> | (1.6)% | (1.5)% | (1.6)% | (2.3)% | (1.9)% |
| Adjusted combined ratio | 174.0% | 82.1% | 147.1% | 108.8% | 126.4% |

---

(1)Adjustment for acquisition related purchase accounting includes the amortization of the acquisition related intangible assets and purchase accounting adjustments related to the net amortization (accretion) of VOBA and acquisition costs, and the fair value adjustments to the net reserve for claims and claim expenses for the acquisitions of Validus, TMR and Platinum.

## Exhibit 99.2

![march 312026.jpg](march 312026.jpg)

------

---

| |
|:---|
| **RenaissanceRe Holdings Ltd.** |
| **Contents** |

---

---

| | | |
|:---|:---|:---|
| | | Page |
| **Basis of Presentation** | **Basis of Presentation** | <u>[i](#i383500058226444b829aa2dd98750c63_7)</u> |
| **Financial Highlights** | **Financial Highlights** | <u>[1](#i383500058226444b829aa2dd98750c63_13)</u> |
| **Summary Consolidated Financial Statements** | **Summary Consolidated Financial Statements** |  |
| a. | Consolidated Statements of Operations | <u>[3](#i383500058226444b829aa2dd98750c63_22)</u> |
| b. | Consolidated Balance Sheets | <u>[4](#i383500058226444b829aa2dd98750c63_25)</u> |
| **Underwriting and Reserves** | **Underwriting and Reserves** |  |
| a. | Segment Underwriting Results | <u>[5](#i383500058226444b829aa2dd98750c63_31)</u> |
| b. | Segment Underwriting Results - Five Quarter Trend | <u>[6](#i383500058226444b829aa2dd98750c63_37)</u> |
| c. | Property Segment - Catastrophe and Other Property Underwriting Results | <u>[9](#i383500058226444b829aa2dd98750c63_40)</u> |
| d. | Gross Premiums Written | <u>[10](#i383500058226444b829aa2dd98750c63_46)</u> |
| e. | Net Premiums Written | <u>[11](#i383500058226444b829aa2dd98750c63_49)</u> |
| f. | Net Premiums Earned | <u>[12](#i383500058226444b829aa2dd98750c63_52)</u> |
| g. | Reserves for Claims and Claim Expenses | <u>[13](#i383500058226444b829aa2dd98750c63_55)</u> |
| h. | Paid to Incurred Analysis | <u>[14](#i383500058226444b829aa2dd98750c63_58)</u> |
| **Managed Joint Ventures and Fee Income** | **Managed Joint Ventures and Fee Income** |  |
| a. | Fee Income | <u>[15](#i383500058226444b829aa2dd98750c63_64)</u> |
| b. | Fee Income - Five Quarter Trend | <u>[16](#i383500058226444b829aa2dd98750c63_67)</u> |
| c. | Noncontrolling Interests | <u>[17](#i383500058226444b829aa2dd98750c63_70)</u> |
| d. | DaVinciRe Holdings Ltd. and Subsidiary Consolidated Statements of Operations | <u>[19](#i383500058226444b829aa2dd98750c63_73)</u> |
| **Investments** | **Investments** |  |
| a. | Total Investment Result | <u>[20](#i383500058226444b829aa2dd98750c63_79)</u> |
| b. | Investments Composition | <u>[21](#i383500058226444b829aa2dd98750c63_85)</u> |
| c. | Managed Investments - Credit Rating | <u>[22](#i383500058226444b829aa2dd98750c63_88)</u> |
| d. | Retained Investments - Credit Rating | <u>[23](#i383500058226444b829aa2dd98750c63_91)</u> |
| **Other Items** | **Other Items** |  |
| a. | Earnings per Share | <u>[24](#i383500058226444b829aa2dd98750c63_97)</u> |
| **Comments on Non-GAAP Financial Measures** | **Comments on Non-GAAP Financial Measures** | <u>[25](#i383500058226444b829aa2dd98750c63_100)</u> |

---

![rnrlogo_regmar25xmedres1.jpg](rnrlogo_regmar25xmedres1.jpg)

------

---

| |
|:---|
| **RenaissanceRe Holdings Ltd.** |
| **Basis of Presentation** |

---

RenaissanceRe Holdings Ltd. (the "Company" or "RenaissanceRe") is a global provider of reinsurance and insurance that specializes in matching well-structured risks with efficient sources of capital. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. Established in 1993, and headquartered in Bermuda, RenaissanceRe has offices across North America, Europe, and the Asia-Pacific region.

This financial supplement includes certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP") including "operating income (loss) available (attributable) to RenaissanceRe common shareholders," "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted," "operating return on average common equity - annualized," "tangible book value per common share," "tangible book value per common share plus accumulated dividends," "adjusted combined ratio," "retained total investment result," "retained investments, at fair value," "retained investments, unrealized gain (loss)" and "operating (income) loss attributable to redeemable noncontrolling interests." A reconciliation of such measures to the most comparable GAAP figures is presented in the attached supplemental financial data. See pages <u>[25](#i383500058226444b829aa2dd98750c63_100)</u> through <u>[33](#i383500058226444b829aa2dd98750c63_127)</u> for "Comments on Non-GAAP Financial Measures."

All information contained herein is unaudited. Unless otherwise noted, amounts are in thousands of United States Dollars, except for share and per share amounts and ratio information. Certain prior period comparatives have been reclassified to conform to the current presentation. This supplement is being provided for informational purposes only. It should be read in conjunction with documents filed by RenaissanceRe with the U.S. Securities and Exchange Commission, including its Annual Reports on Form 10-K and its Quarterly Reports on Form 10-Q. Please refer to the Company's website at <u>www.renre.com</u> for further information about RenaissanceRe.

 i

------

**Cautionary Statement Regarding Forward-Looking Statements**<br>

Any forward-looking statements made in this Financial Supplement reflect RenaissanceRe's current views with respect to future events and financial performance and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company may also make forward-looking statements with respect to its business and industry, such as those relating to its strategy and management objectives, plans and expectations regarding its response and ability to adapt to changing economic conditions, market standing and product volumes, estimates of net negative impact and insured losses from loss events, competition in the industry and government initiatives and regulatory matters affecting the (re)insurance industries. The inclusion of forward-looking statements in this report should not be considered as a representation by the Company that its current objectives or plans will be achieved. Numerous factors could cause the Company's actual results to differ materially from those addressed by the forward-looking statements, including the following: the Company's exposure to natural and non-natural catastrophic events and circumstances and the variance they may cause in the Company's financial results; the effect of climate change on the Company's business, including the trend towards increasingly frequent and severe climate events; the effectiveness of the Company's claims and claim expense reserving process; the effect of emerging claims and coverage issues; the performance of the Company's investment portfolio and financial market volatility; the effects of inflation; the Company's exposure to ceding companies and delegated authority counterparties and the risks they underwrite; the Company's ability to maintain its financial strength ratings; the Company's reliance on a small number of brokers; the highly competitive nature of the Company's industry; the historically cyclical nature of the (re)insurance industries; collection on claimed retrocessional coverage and new retrocessional reinsurance being available; the Company's ability to attract and retain key executives and employees; the Company's ability to successfully implement its business strategies and initiatives; the Company's exposure to credit loss from counterparties; the Company's need to make many estimates and judgments in the preparation of its financial statements; the Company's exposure to risks associated with its management of capital on behalf of investors; changes to the accounting rules and regulatory systems applicable to the Company's business, including changes in Bermuda and U.S. laws or regulations; the effect of current or future macroeconomic or geopolitical events or trends, including the ongoing conflicts globally; other political, regulatory or industry initiatives adversely impacting the Company; the impact of cybersecurity risks, including technology breaches or failure; the Company's ability to comply with covenants in its debt agreements; the effect of adverse economic factors, including changes in the prevailing interest rates; the effects of new or possible future tax actions or reform legislation and regulations in the jurisdictions in which the Company operates; the Company's ability to determine any impairments taken on its investments; the Company's ability to raise capital on acceptable terms; the Company's ability to comply with applicable sanctions and foreign corrupt practices laws; the Company's dependence on capital distributions from its operating subsidiaries; and other factors affecting future results disclosed in RenaissanceRe's filings with the SEC, including its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.

 ii

------

---

| | | |
|:---|:---|:---|
| **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** |
| **Financial Highlights** | **Financial Highlights** | **Financial Highlights** |
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| &nbsp;&nbsp;&nbsp;Net income (loss) available (attributable) to RenaissanceRe common shareholders | $284535 | $161147 |
| &nbsp;&nbsp;Operating income (loss) available (attributable) to RenaissanceRe common shareholders <sup>(1)</sup> | $590537 | $(69754) |
| **Underwriting income** |  |  |
| &nbsp;&nbsp;&nbsp;Gross premiums written | $3478873 | $4155503 |
| &nbsp;&nbsp;&nbsp;Net premiums written | 2678296 | 3443529 |
| &nbsp;&nbsp;Net premiums earned | 2183614 | 2720781 |
| &nbsp;&nbsp;&nbsp;Underwriting income (loss) | 588758 | (770597) |
| Net claims and claim expense ratio: |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | 52.5% | 108.0% |
| &nbsp;&nbsp;&nbsp;Prior accident years | (7.4)% | (7.2)% |
| &nbsp;&nbsp;&nbsp;Calendar year | 45.1% | 100.8% |
| &nbsp;&nbsp;&nbsp;Acquisition expense ratio | 23.8% | 23.8% |
| &nbsp;&nbsp;&nbsp;Operating expense ratio | 4.1% | 3.7% |
| &nbsp;&nbsp;&nbsp;Combined ratio | 73.0% | 128.3% |
| &nbsp;&nbsp;Adjusted combined ratio <sup>(1)</sup> | 72.0% | 126.4% |
| **Fee income** |  |  |
| &nbsp;&nbsp;&nbsp;Management fee income | $47927 | $46061 |
| &nbsp;&nbsp;&nbsp;Performance fee income | 46199 | (15604) |
| &nbsp;&nbsp;&nbsp;Total fee income | $94126 | $30457 |
| **Investment results - managed** |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income | $420502 | $405353 |
| &nbsp;&nbsp;Equity in earnings (losses) of other ventures <sup>(2)</sup> | 20485 | 17828 |
| &nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) on investments | (421913) | 332940 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investment result <sup>(2)</sup> | $19074 | $756121 |
| **Investment results - retained** <sup>(1)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income | $304144 | $279106 |
| &nbsp;&nbsp;Equity in earnings (losses) of other ventures <sup>(2)</sup> | 20485 | 17828 |
| &nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) on investments | (356754) | 328312 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investment result <sup>(2)</sup> | $(32125) | $625246 |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

(2)In the fourth quarter of 2025, the Company revised its presentation of "total investment result" to include equity in earnings (losses) of other ventures. Comparative information for the prior periods presented have been updated to conform to the current presentation.

 1

------

---

| | | |
|:---|:---|:---|
| **Financial Highlights - Per Share Data & ROE** | **Financial Highlights - Per Share Data & ROE** | **Financial Highlights - Per Share Data & ROE** |
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| &nbsp;&nbsp;&nbsp;Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - basic | $6.60 | $3.29 |
| &nbsp;&nbsp;&nbsp;Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted | $6.57 | $3.27 |
| &nbsp;&nbsp;Operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted <sup>(1)</sup> | $13.75 | $(1.49) |
| &nbsp;&nbsp;&nbsp;Average shares outstanding - basic | 42434 | 48334 |
| &nbsp;&nbsp;&nbsp;Average shares outstanding - diluted | 42628 | 48514 |
| &nbsp;&nbsp;&nbsp;Return on average common equity - annualized | 10.5% | 6.6% |
| &nbsp;&nbsp;Operating return on average common equity - annualized <sup>(1)</sup> | 21.8% | (2.9)% |
|  | **March 31,<br>2026** | **December 31,<br>2025** |
| &nbsp;&nbsp;&nbsp;Book value per common share | $250.48 | $247.00 |
| &nbsp;&nbsp;Tangible book value per common share <sup>(1)</sup> | $233.49 | $230.10 |
| &nbsp;&nbsp;Tangible book value per common share plus accumulated dividends <sup>(1)</sup> | $263.58 | $259.78 |
| &nbsp;&nbsp;&nbsp;Year to date change in book value per common share plus change in accumulated dividends | 1.6% | 27.0% |
| &nbsp;&nbsp;Year to date change in tangible book value per common share plus change in accumulated dividends <sup>(1)</sup> | 1.7% | 30.8% |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

 2

------

---

| | | |
|:---|:---|:---|
| **Summary Consolidated Financial Statements** | **Summary Consolidated Financial Statements** | **Summary Consolidated Financial Statements** |
| **Consolidated Statements of Operations** | **Consolidated Statements of Operations** | **Consolidated Statements of Operations** |
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| **Revenues** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross premiums written | $3478873 | $4155503 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net premiums written | $2678296 | $3443529 |
| &nbsp;&nbsp;&nbsp;&nbsp;Decrease (increase) in unearned premiums | (494682) | (722748) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net premiums earned | 2183614 | 2720781 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 420502 | 405353 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange gains (losses) | (9019) | (7328) |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in earnings (losses) of other ventures | 20485 | 17828 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (loss) | 1247 | 914 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) on investments | (421913) | 332940 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total revenues*** | 2194916 | 3470488 |
| **Expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net claims and claim expenses incurred | 983971 | 2743758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition expenses | 521850 | 647435 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operational expenses | 89035 | 100185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate expenses | 19460 | 22810 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 31786 | 27086 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total expenses*** | 1646102 | 3541274 |
| Income (loss) before taxes | 548814 | (70786) |
| Income tax benefit (expense) | (32984) | 45525 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Net income (loss)*** | 515830 | (25261) |
| Net (income) loss attributable to redeemable noncontrolling interests | (222451) | 195252 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Net income (loss) attributable to RenaissanceRe*** | 293379 | 169991 |
| Dividends on preference shares | (8844) | (8844) |
| &nbsp;&nbsp;&nbsp;&nbsp;***Net income (loss) available (attributable) to RenaissanceRe common shareholders*** | $284535 | $161147 |

---

 3

------

---

| | | |
|:---|:---|:---|
| **Summary Consolidated Financial Statements** | **Summary Consolidated Financial Statements** | **Summary Consolidated Financial Statements** |
| **Consolidated Balance Sheets** | **Consolidated Balance Sheets** | **Consolidated Balance Sheets** |
| | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets** | | |
| Fixed maturity investments trading, at fair value – amortized cost $24,893,245 at March 31, 2026 (December 31, 2025 – $24,658,351) | $24901291 | $24884323 |
| Short term investments, at fair value – amortized cost $3,887,637 at March 31, 2026 (December 31, 2025 – $4,760,027) | 3883610 | 4759811 |
| Equity investments, at fair value | 1594284 | 1732990 |
| Other investments, at fair value | 4651495 | 4574214 |
| Investments in other ventures, under equity method | 140853 | 121871 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | 35171533 | 36073209 |
| Cash and cash equivalents | 1562883 | 1731181 |
| Premiums receivable | 8097885 | 7252454 |
| Prepaid reinsurance premiums | 1354841 | 993781 |
| Reinsurance recoverable | 3730957 | 3899913 |
| Accrued investment income | 234709 | 233688 |
| Deferred acquisition costs and value of business acquired | 1665666 | 1538540 |
| Deferred tax asset | 705661 | 701927 |
| Receivable for investments sold | 182534 | 414523 |
| Other assets | 393908 | 328087 |
| Goodwill and other intangibles | 617772 | 633087 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total assets*** | $53718349 | $53800390 |
| **Liabilities, Noncontrolling Interests and Shareholders' Equity** |  |  |
| **Liabilities** |  |  |
| Reserve for claims and claim expenses | $22291058 | $22302345 |
| Unearned premiums | 6885462 | 6028174 |
| Debt | 2330051 | 2329201 |
| Reinsurance balances payable | 2821884 | 2540518 |
| Payable for investments purchased | 308635 | 533101 |
| Other liabilities | 523894 | 856302 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total liabilities*** | 35160984 | 34589641 |
| Redeemable noncontrolling interests | 7043124 | 7602092 |
| **Shareholders' Equity** |  |  |
| Preference shares: $1.00 par value – 30,000 shares issued and outstanding at March 31, 2026 (December 31, 2025 – 30,000) | 750000 | 750000 |
| Common shares: $1.00 par value – 42,973,774 shares issued and outstanding at March 31, 2026 (December 31, 2025 – 43,961,539) | 42974 | 43962 |
| Additional paid-in capital |  |  |
| Accumulated other comprehensive loss | (12152) | (12626) |
| Retained earnings | 10733419 | 10827321 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total shareholders' equity attributable to RenaissanceRe*** | 11514241 | 11608657 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total liabilities, noncontrolling interests and shareholders' equity*** | $53718349 | $53800390 |
| **Book value per common share** | $250.48 | $247.00 |

---

 4

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Segment Underwriting Results** | **Segment Underwriting Results** | **Segment Underwriting Results** | **Segment Underwriting Results** | **Segment Underwriting Results** | **Segment Underwriting Results** | **Segment Underwriting Results** |
| | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** |
| | **Property** | **Casualty and Specialty** | **Total** | **Property** | **Casualty and Specialty** | **Total** |
| Gross premiums written | $1707420 | $1771453 | $3478873 | $2130833 | $2024670 | $4155503 |
| Net premiums written | $1255193 | $1423103 | $2678296 | $1690994 | $1752535 | $3443529 |
| Net premiums earned | $900738 | $1282876 | $2183614 | $1247950 | $1472831 | $2720781 |
| Net claims and claim expenses incurred | 84108 | 899863 | 983971 | 1623257 | 1120501 | 2743758 |
| Acquisition expenses | 157031 | 364819 | 521850 | 167645 | 479790 | 647435 |
| Operational expenses | 65736 | 23299 | 89035 | 64266 | 35919 | 100185 |
| Underwriting income (loss) | $593863 | $(5105) | $588758 | $(607218) | $(163379) | $(770597) |
| Net claims and claim expenses incurred: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | $244849 | $901137 | $1145986 | $1810315 | $1129317 | $2939632 |
| &nbsp;&nbsp;&nbsp;Prior accident years | (160741) | (1274) | (162015) | (187058) | (8816) | (195874) |
| &nbsp;&nbsp;&nbsp;Total | $84108 | $899863 | $983971 | $1623257 | $1120501 | $2743758 |
| Net claims and claim expense ratio: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | 27.2% | 70.2% | 52.5% | 145.1% | 76.7% | 108.0% |
| &nbsp;&nbsp;&nbsp;Prior accident years | (17.9)% | (0.1)% | (7.4)% | (15.0)% | (0.6)% | (7.2)% |
| &nbsp;&nbsp;&nbsp;Calendar year | 9.3% | 70.1% | 45.1% | 130.1% | 76.1% | 100.8% |
| Acquisition expense ratio | 17.5% | 28.5% | 23.8% | 13.5% | 32.5% | 23.8% |
| Operating expense ratio | 7.3% | 1.8% | 4.1% | 5.1% | 2.5% | 3.7% |
| Combined ratio | 34.1% | 100.4% | 73.0% | 148.7% | 111.1% | 128.3% |
| Adjusted combined ratio <sup>(1)</sup> | 33.0% | 99.4% | 72.0% | 147.1% | 108.8% | 126.4% |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

 5

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Underwriting Results - Five Quarter Trend** | **Underwriting Results - Five Quarter Trend** | **Underwriting Results - Five Quarter Trend** | **Underwriting Results - Five Quarter Trend** | **Underwriting Results - Five Quarter Trend** | **Underwriting Results - Five Quarter Trend** |
| | **Total** | **Total** | **Total** | **Total** | **Total** |
| | **March 31,<br>2026** | **December 31,<br>2025** | **September 30,<br>2025** | **June 30,<br>2025** | **March 31,<br>2025** |
| Gross premiums written | $3478873 | $1838111 | $2323626 | $3421180 | $4155503 |
| Net premiums written | $2678296 | $1598599 | $2057802 | $2770270 | $3443529 |
| Net premiums earned | $2183614 | $2334442 | $2433805 | $2412154 | $2720781 |
| Net claims and claim expenses incurred | 983971 | 951138 | 878820 | 1042123 | 2743758 |
| Acquisition expenses | 521850 | 601060 | 659723 | 642605 | 647435 |
| Operational expenses | 89035 | 113481 | 125073 | 125738 | 100185 |
| Underwriting income (loss) | $588758 | $668763 | $770189 | $601688 | $(770597) |
| Net claims and claim expenses incurred: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | $1145986 | $1196436 | $1258871 | $1311833 | $2939632 |
| &nbsp;&nbsp;&nbsp;Prior accident years | (162015) | (245298) | (380051) | (269710) | (195874) |
| &nbsp;&nbsp;&nbsp;Total | $983971 | $951138 | $878820 | $1042123 | $2743758 |
| Net claims and claim expense ratio: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | 52.5% | 51.3% | 51.7% | 54.4% | 108.0% |
| &nbsp;&nbsp;&nbsp;Prior accident years | (7.4)% | (10.6)% | (15.6)% | (11.2)% | (7.2)% |
| &nbsp;&nbsp;&nbsp;Calendar year | 45.1% | 40.7% | 36.1% | 43.2% | 100.8% |
| Acquisition expense ratio | 23.8% | 25.8% | 27.2% | 26.7% | 23.8% |
| Operating expense ratio | 4.1% | 4.9% | 5.1% | 5.2% | 3.7% |
| Combined ratio | 73.0% | 71.4% | 68.4% | 75.1% | 128.3% |
| Adjusted combined ratio <sup>(1)</sup> | 72.0% | 70.0% | 66.6% | 73.0% | 126.4% |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

 6

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Property Segment Underwriting Results - Five Quarter Trend** | **Property Segment Underwriting Results - Five Quarter Trend** | **Property Segment Underwriting Results - Five Quarter Trend** | **Property Segment Underwriting Results - Five Quarter Trend** | **Property Segment Underwriting Results - Five Quarter Trend** | **Property Segment Underwriting Results - Five Quarter Trend** |
| | **Property** | **Property** | **Property** | **Property** | **Property** |
| | **March 31,<br>2026** | **December 31,<br>2025** | **September 30,<br>2025** | **June 30,<br>2025** | **March 31,<br>2025** |
| Gross premiums written | $1707420 | $346099 | $733274 | $1731935 | $2130833 |
| Net premiums written | $1255193 | $333320 | $694125 | $1325557 | $1690994 |
| Net premiums earned | $900738 | $918776 | $936933 | $868010 | $1247950 |
| Net claims and claim expenses incurred | 84108 | (55808) | (133504) | (7930) | 1623257 |
| Acquisition expenses | 157031 | 180660 | 192347 | 174200 | 167645 |
| Operational expenses | 65736 | 75067 | 86579 | 71569 | 64266 |
| Underwriting income (loss) | $593863 | $718857 | $791511 | $630171 | $(607218) |
| Net claims and claim expenses incurred: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | $244849 | $196081 | $250169 | $258646 | $1810315 |
| &nbsp;&nbsp;&nbsp;Prior accident years | (160741) | (251889) | (383673) | (266576) | (187058) |
| &nbsp;&nbsp;&nbsp;Total | $84108 | $(55808) | $(133504) | $(7930) | $1623257 |
| Net claims and claim expense ratio: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | 27.2% | 21.3% | 26.7% | 29.8% | 145.1% |
| &nbsp;&nbsp;&nbsp;Prior accident years | (17.9)% | (27.4)% | (40.9)% | (30.7)% | (15.0)% |
| &nbsp;&nbsp;&nbsp;Calendar year | 9.3% | (6.1)% | (14.2)% | (0.9)% | 130.1% |
| Acquisition expense ratio | 17.5% | 19.7% | 20.5% | 20.1% | 13.5% |
| Operating expense ratio | 7.3% | 8.2% | 9.2% | 8.2% | 5.1% |
| Combined ratio | 34.1% | 21.8% | 15.5% | 27.4% | 148.7% |
| Adjusted combined ratio <sup>(1)</sup> | 33.0% | 20.4% | 14.2% | 25.8% | 147.1% |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

 7

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Casualty and Specialty Segment Underwriting Results - Five Quarter Trend** | **Casualty and Specialty Segment Underwriting Results - Five Quarter Trend** | **Casualty and Specialty Segment Underwriting Results - Five Quarter Trend** | **Casualty and Specialty Segment Underwriting Results - Five Quarter Trend** | **Casualty and Specialty Segment Underwriting Results - Five Quarter Trend** | **Casualty and Specialty Segment Underwriting Results - Five Quarter Trend** |
| | **Casualty and Specialty** | **Casualty and Specialty** | **Casualty and Specialty** | **Casualty and Specialty** | **Casualty and Specialty** |
| | **March 31,<br>2026** | **December 31,<br>2025** | **September 30,<br>2025** | **June 30,<br>2025** | **March 31,<br>2025** |
| Gross premiums written | $1771453 | $1492012 | $1590352 | $1689245 | $2024670 |
| Net premiums written | $1423103 | $1265279 | $1363677 | $1444713 | $1752535 |
| Net premiums earned | $1282876 | $1415666 | $1496872 | $1544144 | $1472831 |
| Net claims and claim expenses incurred | 899863 | 1006946 | 1012324 | 1050053 | 1120501 |
| Acquisition expenses | 364819 | 420400 | 467376 | 468405 | 479790 |
| Operational expenses | 23299 | 38414 | 38494 | 54169 | 35919 |
| Underwriting income (loss) | $(5105) | $(50094) | $(21322) | $(28483) | $(163379) |
| Net claims and claim expenses incurred: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | $901137 | $1000355 | $1008702 | $1053187 | $1129317 |
| &nbsp;&nbsp;&nbsp;Prior accident years | (1274) | 6591 | 3622 | (3134) | (8816) |
| &nbsp;&nbsp;&nbsp;Total | $899863 | $1006946 | $1012324 | $1050053 | $1120501 |
| Net claims and claim expense ratio: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | 70.2% | 70.7% | 67.4% | 68.2% | 76.7% |
| &nbsp;&nbsp;&nbsp;Prior accident years | (0.1)% | 0.4% | 0.2% | (0.2)% | (0.6)% |
| &nbsp;&nbsp;&nbsp;Calendar year | 70.1% | 71.1% | 67.6% | 68.0% | 76.1% |
| Acquisition expense ratio | 28.5% | 29.7% | 31.2% | 30.3% | 32.5% |
| Operating expense ratio | 1.8% | 2.7% | 2.6% | 3.5% | 2.5% |
| Combined ratio | 100.4% | 103.5% | 101.4% | 101.8% | 111.1% |
| Adjusted combined ratio <sup>(1)</sup> | 99.4% | 102.3% | 99.3% | 99.5% | 108.8% |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

 8

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Property Segment - Catastrophe and Other Property Underwriting Results** | **Property Segment - Catastrophe and Other Property Underwriting Results** | **Property Segment - Catastrophe and Other Property Underwriting Results** | **Property Segment - Catastrophe and Other Property Underwriting Results** | **Property Segment - Catastrophe and Other Property Underwriting Results** | **Property Segment - Catastrophe and Other Property Underwriting Results** | **Property Segment - Catastrophe and Other Property Underwriting Results** |
| | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** |
| | **Catastrophe** | **Other Property** | **Total** | **Catastrophe** | **Other Property** | **Total** |
| Gross premiums written | $1279607 | $427813 | $1707420 | $1666641 | $464192 | $2130833 |
| Net premiums written | $998122 | $257071 | $1255193 | $1411050 | $279944 | $1690994 |
| Net premiums earned | $562721 | $338017 | $900738 | $882819 | $365131 | $1247950 |
| Net claims and claim expenses incurred | (5443) | 89551 | 84108 | 1431394 | 191863 | 1623257 |
| Acquisition expenses | 64641 | 92390 | 157031 | 66581 | 101064 | 167645 |
| Operational expenses | 55567 | 10169 | 65736 | 51837 | 12429 | 64266 |
| Underwriting income (loss) | $447956 | $145907 | $593863 | $(666993) | $59775 | $(607218) |
| Net claims and claim expenses incurred: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | $57201 | $187648 | $244849 | $1498773 | $311542 | $1810315 |
| &nbsp;&nbsp;&nbsp;Prior accident years | (62644) | (98097) | (160741) | (67379) | (119679) | (187058) |
| &nbsp;&nbsp;&nbsp;Total | $(5443) | $89551 | $84108 | $1431394 | $191863 | $1623257 |
| Net claims and claim expense ratio: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current accident year | 10.2% | 55.5% | 27.2% | 169.8% | 85.3% | 145.1% |
| &nbsp;&nbsp;&nbsp;Prior accident years | (11.2)% | (29.0)% | (17.9)% | (7.7)% | (32.8)% | (15.0)% |
| &nbsp;&nbsp;&nbsp;Calendar year | (1.0)% | 26.5% | 9.3% | 162.1% | 52.5% | 130.1% |
| Acquisition expense ratio | 11.5% | 27.3% | 17.5% | 7.6% | 27.7% | 13.5% |
| Operating expense ratio | 9.9% | 3.0% | 7.3% | 5.9% | 3.4% | 5.1% |
| Combined ratio | 20.4% | 56.8% | 34.1% | 175.6% | 83.6% | 148.7% |
| Adjusted combined ratio <sup>(1)</sup> | 19.2% | 56.1% | 33.0% | 174.0% | 82.1% | 147.1% |

---

(1)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

 9

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Gross Premiums Written** | **Gross Premiums Written** | **Gross Premiums Written** | **Gross Premiums Written** | **Gross Premiums Written** |
| | **Three months ended** | **Three months ended** | **Q/Q $**<br>**Change** | **Q/Q % Change** |
| | **March 31,<br>2026** | **March 31,<br>2025** | **Q/Q $**<br>**Change** | **Q/Q % Change** |
| **<u>Property Segment</u>** | | | | |
| Catastrophe | $1285442 | $1328261 | $(42819) | (3.2)% |
| Catastrophe - gross reinstatement premiums | (5835) | 338380 | (344215) | (101.7)% |
| &nbsp;&nbsp;&nbsp;Total catastrophe gross premiums written | 1279607 | 1666641 | (387034) | (23.2)% |
| Other property | 428612 | 462717 | (34105) | (7.4)% |
| Other property - gross reinstatement premiums | (799) | 1475 | (2274) | (154.2)% |
| &nbsp;&nbsp;&nbsp;Total other property gross premiums written | 427813 | 464192 | (36379) | (7.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property segment gross premiums written | $1707420 | $2130833 | $(423413) | (19.9)% |
| **<u>Casualty and Specialty Segment</u>** |  |  |  |  |
| General casualty <sup>(1)</sup> | $500958 | $680449 | $(179491) | (26.4)% |
| Professional liability <sup>(2)</sup> | 299696 | 236961 | 62735 | 26.5% |
| Credit <sup>(3)</sup> | 359304 | 400753 | (41449) | (10.3)% |
| Other specialty <sup>(4)</sup> | 611495 | 706507 | (95012) | (13.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Casualty and Specialty segment gross premiums written | $1771453 | $2024670 | $(253217) | (12.5)% |

---

(1)Includes automobile liability, casualty clash, employers' liability, umbrella or excess casualty, workers' compensation and general liability.

(2)Includes directors and officers, medical malpractice, professional indemnity and transactional liability.

(3)Includes financial guaranty, mortgage guaranty, political risk, surety and trade credit.

(4)Includes accident and health, agriculture, aviation, construction, cyber, energy, marine, satellite and terrorism. Lines of business such as regional multi-line and whole account may have characteristics of various other lines of business, and are allocated accordingly.

 10

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Net Premiums Written** | **Net Premiums Written** | **Net Premiums Written** | **Net Premiums Written** | **Net Premiums Written** |
| | **Three months ended** | **Three months ended** | **Q/Q $**<br>**Change** | **Q/Q % Change** |
| | **March 31,<br>2026** | **March 31,<br>2025** | **Q/Q $**<br>**Change** | **Q/Q % Change** |
| **<u>Property Segment</u>** | | | | |
| Catastrophe | $1000555 | $1077335 | $(76780) | (7.1)% |
| Catastrophe - net reinstatement premiums | (2433) | 333715 | (336148) | (100.7)% |
| &nbsp;&nbsp;&nbsp;Total catastrophe net premiums written | 998122 | 1411050 | (412928) | (29.3)% |
| Other property | 258341 | 278395 | (20054) | (7.2)% |
| Other property - net reinstatement premiums | (1270) | 1549 | (2819) | (182.0)% |
| &nbsp;&nbsp;&nbsp;Total other property net premiums written | 257071 | 279944 | (22873) | (8.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property segment net premiums written | $1255193 | $1690994 | $(435801) | (25.8)% |
| **<u>Casualty and Specialty Segment</u>** |  |  |  |  |
| General casualty <sup>(1)</sup> | $434097 | $633167 | $(199070) | (31.4)% |
| Professional liability <sup>(2)</sup> | 250246 | 221721 | 28525 | 12.9% |
| Credit <sup>(3)</sup> | 291291 | 345821 | (54530) | (15.8)% |
| Other specialty <sup>(4)</sup> | 447469 | 551826 | (104357) | (18.9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Casualty and Specialty segment net premiums written | $1423103 | $1752535 | $(329432) | (18.8)% |

---

(1)Includes automobile liability, casualty clash, employers' liability, umbrella or excess casualty, workers' compensation and general liability.

(2)Includes directors and officers, medical malpractice, professional indemnity and transactional liability.

(3)Includes financial guaranty, mortgage guaranty, political risk, surety and trade credit.

(4)Includes accident and health, agriculture, aviation, construction, cyber, energy, marine, satellite and terrorism. Lines of business such as regional multi-line and whole account may have characteristics of various other lines of business, and are allocated accordingly.

 11

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Net Premiums Earned** | **Net Premiums Earned** | **Net Premiums Earned** | **Net Premiums Earned** | **Net Premiums Earned** |
| | **Three months ended** | **Three months ended** | **Q/Q $**<br>**Change** | **Q/Q % Change** |
| | **March 31,<br>2026** | **March 31,<br>2025** | **Q/Q $**<br>**Change** | **Q/Q % Change** |
| **<u>Property Segment</u>** | | | | |
| Catastrophe | $565154 | $549104 | $16050 | 2.9% |
| Catastrophe - net reinstatement premiums | (2433) | 333715 | (336148) | (100.7)% |
| &nbsp;&nbsp;&nbsp;Total catastrophe net premiums earned | 562721 | 882819 | (320098) | (36.3)% |
| Other property | 339287 | 363582 | (24295) | (6.7)% |
| Other property - net reinstatement premiums | (1270) | 1549 | (2819) | (182.0)% |
| &nbsp;&nbsp;&nbsp;Total other property net premiums earned | 338017 | 365131 | (27114) | (7.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property segment net premiums earned | $900738 | $1247950 | $(347212) | (27.8)% |
| **<u>Casualty and Specialty Segment</u>** |  |  |  |  |
| General casualty <sup>(1)</sup> | $436766 | $608597 | $(171831) | (28.2)% |
| Professional liability <sup>(2)</sup> | 274130 | 202729 | 71401 | 35.2% |
| Credit <sup>(3)</sup> | 184303 | 211614 | (27311) | (12.9)% |
| Other specialty <sup>(4)</sup> | 387677 | 449891 | (62214) | (13.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Casualty and Specialty segment net premiums earned | $1282876 | $1472831 | $(189955) | (12.9)% |

---

(1)Includes automobile liability, casualty clash, employers' liability, umbrella or excess casualty, workers' compensation and general liability.

(2)Includes directors and officers, medical malpractice, professional indemnity and transactional liability.

(3)Includes financial guaranty, mortgage guaranty, political risk, surety and trade credit.

(4)Includes accident and health, agriculture, aviation, construction, cyber, energy, marine, satellite and terrorism. Lines of business such as regional multi-line and whole account may have characteristics of various other lines of business, and are allocated accordingly.

 12

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Reserves for Claims and Claim Expenses** | **Reserves for Claims and Claim Expenses** | **Reserves for Claims and Claim Expenses** | **Reserves for Claims and Claim Expenses** | **Reserves for Claims and Claim Expenses** |
| | **Case Reserves** | **Additional Case Reserves** | **IBNR** | **Total** |
| **<u>March 31, 2026</u>** | | | | |
| Property | $1749063 | $1562377 | $2039860 | $5351300 |
| Casualty and Specialty | 3645622 | 334902 | 12959234 | 16939758 |
| &nbsp;&nbsp;&nbsp;Total | $5394685 | $1897279 | $14999094 | $22291058 |
| **<u>December 31, 2025</u>** |  |  |  |  |
| Property | $1797427 | $1679848 | $2208709 | $5685984 |
| Casualty and Specialty | 3393451 | 327941 | 12894969 | 16616361 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $5190878 | $2007789 | $15103678 | $22302345 |

---

 13

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** | **RenaissanceRe Holdings Ltd.** |
| **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** | **Underwriting and Reserves** |
| **Paid to Incurred Analysis** | **Paid to Incurred Analysis** | **Paid to Incurred Analysis** | **Paid to Incurred Analysis** | **Paid to Incurred Analysis** | **Paid to Incurred Analysis** | **Paid to Incurred Analysis** |
| | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** |
| | **Gross** | **Recoveries** | **Net** | **Gross** | **Recoveries** | **Net** |
| Reserve for claims and claim expenses, beginning of period | $22302345 | $3899913 | $18402432 | $21303491 | $4481390 | $16822101 |
| Incurred claims and claim expenses |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current year | 1286578 | 140592 | 1145986 | 3455425 | 515793 | 2939632 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior years | (253548) | (91533) | (162015) | (350583) | (154709) | (195874) |
| Total incurred claims and claim expenses | 1033030 | 49059 | 983971 | 3104842 | 361084 | 2743758 |
| Paid claims and claim expenses |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current year | 52143 | 9561 | 42582 | 536752 | 44638 | 492114 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior years | 964845 | 188844 | 776001 | 1084089 | 196057 | 888032 |
| Total paid claims and claim expenses | 1016988 | 198405 | 818583 | 1620841 | 240695 | 1380146 |
| Foreign exchange and other <sup>(1)</sup> | (27329) | (19610) | (7719) | 69639 | (23884) | 93523 |
| Reserve for claims and claim expenses, end of period | $22291058 | $3730957 | $18560101 | $22857131 | $4577895 | $18279236 |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;Reflects the impact of the foreign exchange revaluation of the reserve for claims and claim expenses, net of reinsurance recoverable, denominated in non-U.S. dollars as at the balance sheet date, as well as reinsurance transactions accounted for under retroactive reinsurance accounting.

 14

------

---

| |
|:---|
| **Managed Joint Ventures and Fee Income** |
| **Fee Income** |

---

The table below shows the total fee income earned from third-party capital management activities, including various joint ventures and managed funds, and certain structured reinsurance products.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| Management fee income | $47927 | $46061 |
| Performance fee income (loss) <sup>(1)</sup> | 46199 | (15604) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total fee income | $94126 | $30457 |

---

(1)Performance fees are based on the performance of the individual vehicles or products and may be zero or negative in a particular period. For example, large losses could potentially result in no performance fees or the reversal of previously accrued performance fees.

The table below shows how the total fee income described above contributes to the Company's consolidated results of operations.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| **Fee income contributing to:** | | |
| Net income (loss) attributable to redeemable noncontrolling interests | $72171 | $(8942) |
| Underwriting income (loss) <sup>(1)</sup> | 21955 | 39399 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fee income | $94126 | $30457 |

---

(1)Reflects total fee income earned from third-party capital management activities and certain structured reinsurance products recorded through underwriting income (loss) as a decrease (increase) to operational expenses or acquisition expenses.

 15

------

---

| |
|:---|
| **Managed Joint Ventures and Fee Income** |
| **Fee Income - Five Quarter Trend** |

---

The table below shows the total fee income earned from third-party capital management activities, including various joint ventures and managed funds, and certain structured reinsurance products.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **December 31,<br>2025** | **September 30,<br>2025** | **June 30,<br>2025** | **March 31,<br>2025** |
| Management fee income | $47927 | $52002 | $53014 | $56407 | $46061 |
| Performance fee income (loss) <sup>(1)</sup> | 46199 | 49626 | 48796 | 38550 | (15604) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total fee income | $94126 | $101628 | $101810 | $94957 | $30457 |

---

(1)Performance fees are based on the performance of the individual vehicles or products and may be zero or negative in a particular period. For example, large losses could potentially result in no performance fees or the reversal of previously accrued performance fees.

The table below shows how the total fee income described above contributes to the Company's consolidated results of operations.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **December 31,<br>2025** | **September 30,<br>2025** | **June 30,<br>2025** | **March 31,<br>2025** |
| **Fee income contributing to:** | | | | | |
| Net income (loss) attributable to redeemable noncontrolling interests | $72171 | $87877 | $88689 | $82465 | $(8942) |
| Underwriting income (loss) <sup>(1)</sup> | 21955 | 13751 | 13121 | 12492 | 39399 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fee income | $94126 | $101628 | $101810 | $94957 | $30457 |

---

(1)Reflects total fee income earned from third-party capital management activities and certain structured reinsurance products recorded through underwriting income (loss) as a decrease (increase) to operational expenses or acquisition expenses.

 16

------

---

| |
|:---|
| **Managed Joint Ventures and Fee Income** |
| **Noncontrolling Interests** |

---

The Company consolidates the results of certain of its joint ventures and managed capital vehicles, namely, DaVinciRe Holdings Ltd. ("DaVinci"), RenaissanceRe Medici Fund Ltd. ("Medici"), Vermeer Reinsurance Ltd. ("Vermeer") and Fontana Holdings L.P. and its subsidiaries ("Fontana") (collectively, the "Consolidated Managed Joint Ventures"), on its consolidated balance sheets and statements of operations. Redeemable noncontrolling interests on the Company's consolidated balance sheets represents the portion of the net assets of the Consolidated Managed Joint Ventures attributable to third-party investors in these Consolidated Managed Joint Ventures. Net (income) loss attributable to redeemable noncontrolling interests on the Company's consolidated statements of operations represents the portion of the (income) loss associated with the Consolidated Managed Joint Ventures included on the Company's consolidated statements of operations that is allocated to third-party investors in these Consolidated Managed Joint Ventures.

A summary of the redeemable noncontrolling interests on the Company's consolidated statements of operations is set forth below:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| Redeemable noncontrolling interests - DaVinci | $(156900) | $112441 |
| Redeemable noncontrolling interests - Medici | (19807) | (15163) |
| Redeemable noncontrolling interests - Vermeer | (51699) | 107080 |
| Redeemable noncontrolling interests - Fontana | 5955 | (9106) |
| &nbsp;&nbsp;&nbsp;Net (income) loss attributable to redeemable noncontrolling interests <sup>(1)</sup> | $(222451) | $195252 |

---

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| Operating (income) loss attributable to redeemable noncontrolling interests <sup>(2)</sup> | $(278518) | $235977 |
| Non-operating (income) loss attributable to redeemable noncontrolling interests | 56067 | (40725) |
| &nbsp;&nbsp;&nbsp;Net (income) loss attributable to redeemable noncontrolling interests <sup>(1)</sup> | $(222451) | $195252 |

---

(1)A negative number in the tables above represents net income earned by the Consolidated Managed Joint Ventures allocated to third-party investors. Conversely, a positive number represents net losses incurred by the Consolidated Managed Joint Ventures allocated to third-party investors.

(2)See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

 17

------

---

| |
|:---|
| **Managed Joint Ventures and Fee Income** |
| **Noncontrolling Interests** |

---

A summary of the redeemable noncontrolling interests on the Company's consolidated balance sheets is set forth below:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Redeemable noncontrolling interests - DaVinci | $3291360 | $3701637 |
| Redeemable noncontrolling interests - Medici | 1433068 | 1398166 |
| Redeemable noncontrolling interests - Vermeer | 1824130 | 1922431 |
| Redeemable noncontrolling interests - Fontana | 494566 | 579858 |
| &nbsp;&nbsp;Redeemable noncontrolling interests | $7043124 | $7602092 |

---

A summary of the redeemable noncontrolling economic ownership of third parties in the Company's Consolidated Managed Joint Ventures is set forth below:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| DaVinci | 73.7% | 75.7% |
| Medici | 88.8% | 88.7% |
| Vermeer | 100.0% | 100.0% |
| Fontana | 61.6% | 71.3% |

---

 18

------

---

| | | |
|:---|:---|:---|
| **Managed Joint Ventures and Fee Income** | **Managed Joint Ventures and Fee Income** | **Managed Joint Ventures and Fee Income** |
| **DaVinciRe Holdings Ltd. and Subsidiary** | **DaVinciRe Holdings Ltd. and Subsidiary** | **DaVinciRe Holdings Ltd. and Subsidiary** |
| **Consolidated Statements of Operations and Balance Sheet Data** | **Consolidated Statements of Operations and Balance Sheet Data** | **Consolidated Statements of Operations and Balance Sheet Data** |
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| **Revenues** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross premiums written | $656778 | $854865 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net premiums written | $600189 | $802238 |
| &nbsp;&nbsp;&nbsp;&nbsp;Decrease (increase) in unearned premiums | (290933) | (342462) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net premiums earned | 309256 | 459776 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 65117 | 63412 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange gains (losses) | (1658) | (2384) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized gains (losses) on investments | (49913) | 36488 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total revenues*** | 322802 | 557292 |
| **Expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net claims and claim expenses incurred | (9664) | 697271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition expenses | 84542 | (18392) |
| &nbsp;&nbsp;&nbsp;&nbsp;Operational expenses | 31832 | 22493 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate expenses | 103 | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 4543 | 3198 |
| &nbsp;&nbsp;&nbsp;&nbsp;***Total expenses*** | 111356 | 704608 |
| Income (loss) before taxes | 211446 | (147316) |
| Income tax benefit (expense) | (641) | (1178) |
| &nbsp;&nbsp;&nbsp;&nbsp;***Net income (loss) available (attributable) to DaVinci common shareholders*** | $210805 | $(148494) |
| Net claims and claim expense ratio - current accident year | 12.1% | 158.7% |
| Net claims and claim expense ratio - prior accident years | (15.2)% | (7.0)% |
| Net claims and claim expense ratio - calendar year | (3.1)% | 151.7% |
| Underwriting expense ratio | 37.6% | 0.8% |
| Combined ratio | 34.5% | 152.5% |
| **Balance Sheet Data:** | **March 31,<br>2026** | **December 31,<br>2025** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investments | $5724399 | $6246947 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | 7035483 | 7225478 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reserve for claims and claim expenses | 1408234 | 1485378 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt | 297052 | 296972 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 4349174 | 4888369 |

---

 19

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Investments** | **Investments** | **Investments** | **Investments** | **Investments** |
| **Total Investment Result** | **Total Investment Result** | **Total Investment Result** | **Total Investment Result** | **Total Investment Result** |
| | **Managed** <sup>(1)</sup> | **Managed** <sup>(1)</sup> | **Retained** <sup>(2)</sup> | **Retained** <sup>(2)</sup> |
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** | **March 31,<br>2026** | **March 31,<br>2025** |
| **Net investment income** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity investments trading | $294494 | $284723 | $232641 | $226828 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short term investments | 34306 | 41029 | 13684 | 17913 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed income exchange traded funds | 21692 | 1184 | 21692 | 1184 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock <sup>(3)</sup> | 677 | 726 | 677 | 722 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Catastrophe bonds | 39932 | 54754 | 5288 | 8897 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fund and direct private equity investments <sup>(3)</sup> | 25211 | 18723 | 25119 | 18723 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 11163 | 11110 | 10390 | 10270 |
|  | 427475 | 412249 | 309491 | 284537 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment expenses | (6973) | (6896) | (5347) | (5431) |
| **Net investment income** | $420502 | $405353 | $304144 | $279106 |
| **Equity in earnings (losses) of other ventures** <sup>(4)</sup> | $20485 | $17828 | $20485 | $17828 |
| **Net realized and unrealized gains (losses) on investments** <sup>(5)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed maturity-related investments <sup>(6)</sup> | $(267948) | $312877 | $(215763) | $274754 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity-related investments <sup>(7)</sup> | (147426) | (49589) | (146422) | (49716) |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodity-related investments <sup>(8)</sup> | 65310 | 117591 | 65310 | 117591 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Catastrophe bonds | (11829) | (40413) | (468) | (6791) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fund and direct private equity investments <sup>(3)</sup> | (60020) | (7526) | (59411) | (7526) |
| **Net realized and unrealized gains (losses) on investments** | $(421913) | $332940 | $(356754) | $328312 |
| **Total investment result** <sup>(4)</sup> | $19074 | $756121 | $(32125) | $625246 |
| **Average invested assets** | $35622372 | $33116302 | $25914519 | $23796175 |
| **Net investment income return - annualized** | 4.9% | 5.1% | 4.8% | 4.8% |
| **Total investment return - annualized** <sup>(4)</sup> | 0.3% | 9.6% | (0.5)% | 10.9% |

---

(1)"Managed" represents the consolidated total investment result, which is comprised of net investment income, equity in earnings (losses) of other ventures and net realized and unrealized gains (losses) on investments as presented on the Company's consolidated statements of operations.

(2)"Retained" represents the consolidated total investment result, less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

(3)In the fourth quarter of 2025, the Company revised the description of its "other equity investments" to "common stock" and its "other investments - other" to "other investments - fund and direct private equity investments."

(4)In the fourth quarter of 2025, the Company revised its presentation of "total investment result" and "total investment return - annualized" to include equity in earnings (losses) of other ventures. Comparative information for the prior periods presented have been updated to conform to the current presentation.

(5)In the fourth quarter of 2025, the Company revised its presentation of "net realized and unrealized gains (losses) on investments" to show amounts based on net investment exposure, which takes into account related derivative impacts. Comparative information for the prior periods have been updated to conform to the current presentation.

(6)Includes fixed maturity investments and investment-related derivatives, which includes interest rate futures, credit default swaps and interest rate swaps.

(7)Includes equity investments and investment-related derivatives, which includes equity futures and warrants.

(8)Includes commodity-related derivatives, which includes commodity futures and commodity options.

 20

------

---

| |
|:---|
| **Investments** |
| **Investments Composition** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Managed** <sup>(1)</sup> | **Managed** <sup>(1)</sup> | **Retained** <sup>(2)</sup> | **Retained** <sup>(2)</sup> | **Managed** <sup>(1)</sup> | **Managed** <sup>(1)</sup> | **Retained** <sup>(2)</sup> | **Retained** <sup>(2)</sup> |
| **Type of Investment** | **Fair Value** | **Unrealized Gain (Loss)** | **Fair Value** | **Unrealized Gain (Loss)** | **Fair Value** | **Unrealized Gain (Loss)** | **Fair Value** | **Unrealized Gain (Loss)** |
| **Fixed maturity investments trading, at fair value** | | | | | | | | |
| &nbsp;&nbsp;&nbsp;U.S. treasuries | $10253936 | $46066 | $7488394 | $35709 | $10641503 | $134072 | $7651734 | $101770 |
| &nbsp;&nbsp;&nbsp;Corporate | 8984951 | (18441) | 7372851 | (21646) | 8528828 | 75453 | 6654252 | 49673 |
| &nbsp;&nbsp;Other <sup>(3)</sup> | 5662404 | (19579) | 4835753 | (13745) | 5713992 | 16447 | 4787279 | 18137 |
| **Total fixed maturity investments trading, at fair value** | 24901291 | 8046 | 19696998 | 318 | 24884323 | 225972 | 19093265 | 169580 |
| **Short term investments, at fair value** | 3883610 | (4027) | 1191542 | (3855) | 4759811 | (216) | 1831823 | (10) |
| **Equity investments, at fair value** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed income exchange traded funds | 1359777 | (25313) | 1293249 | (24574) | 1582811 | 26827 | 1582811 | 26827 |
| &nbsp;&nbsp;&nbsp;Equity exchange traded funds | 106569 | (8451) | 106569 | (8451) |  |  |  |  |
| &nbsp;&nbsp;Common stock | 127938 | 80534 | 127265 | 80620 | 150179 | 95243 | 146514 | 95056 |
| **Total equity investments, at fair value** | 1594284 | 46770 | 1527083 | 47595 | 1732990 | 122070 | 1729325 | 121883 |
| **Other investments, at fair value** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Catastrophe bonds | 1609000 | 9582 | 288916 | 475 | 1613710 | 25617 | 231893 | 1445 |
| &nbsp;&nbsp;&nbsp;Fund investments | 2917837 | 383870 | 2903505 | 384611 | 2775499 | 381941 | 2762301 | 382200 |
| &nbsp;&nbsp;&nbsp;Direct private equity investments | 124658 | 11265 | 124658 | 11265 | 185005 | 71612 | 185005 | 71612 |
| **Total other investments, at fair value** | 4651495 | 404717 | 3317079 | 396351 | 4574214 | 479170 | 3179199 | 455257 |
| **Investments in other ventures, under equity method** | 140853 |  | 140853 |  | 121871 |  | 121871 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total investments** | $35171533 | $455506 | $25873555 | $440409 | $36073209 | $826996 | $25955483 | $746710 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
| | **Managed** <sup>(1)</sup> | **Retained** <sup>(2)</sup> | **Managed** <sup>(1)</sup> | **Retained** <sup>(2)</sup> |
| &nbsp;&nbsp;Weighted average yield to maturity of investments <sup>(4)</sup> | 5.1% | 5.1% | 4.8% | 4.8% |
| &nbsp;&nbsp;Average duration of investments, in years <sup>(4)</sup> | 2.9 | 3.4 | 2.6 | 3.0 |
| &nbsp;&nbsp;Unrealized gain (loss) on total fixed maturity investments trading, at fair value, per common share <sup>(5)</sup> |  | $0.01 |  | $3.86 |

---

(1)"Managed" represents the consolidated total investments as presented on the Company's consolidated balance sheets.

(2)"Retained" represents the consolidated total investments, less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

(3)Includes agencies, non-U.S. government, residential mortgage-backed, commercial mortgage-backed and asset-backed securities within the Company's fixed maturity investments trading portfolio.

(4)Excludes equity exchange traded funds, common stock, direct private equity investments, private equity funds, multi-strategy funds, equity funds and investments in other ventures, under equity method as these investments have no final maturity, yield to maturity or duration.

(5)Represents the impact to book value per common share of the unrealized gain (loss) on total fixed maturity investments trading, at fair value. See "Comments on Non-GAAP Financial Measures" for reconciliation of non-GAAP financial measures.

 21

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Investments** | **Investments** | **Investments** | **Investments** | **Investments** | **Investments** | **Investments** | **Investments** | **Investments** |
| **Managed Investments - Credit Rating** <sup>(1)</sup> | **Managed Investments - Credit Rating** <sup>(1)</sup> | **Managed Investments - Credit Rating** <sup>(1)</sup> | **Managed Investments - Credit Rating** <sup>(1)</sup> | **Managed Investments - Credit Rating** <sup>(1)</sup> | **Managed Investments - Credit Rating** <sup>(1)</sup> | **Managed Investments - Credit Rating** <sup>(1)</sup> | **Managed Investments - Credit Rating** <sup>(1)</sup> | **Managed Investments - Credit Rating** <sup>(1)</sup> |
| | | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Investments Not Subject to Credit Ratings** |
| **<u>March 31, 2026</u>** | **Fair Value** | **AAA** | **AA** | **A** | **BBB** | **Non-<br>Investment<br>Grade** | **Not Rated** | **Investments Not Subject to Credit Ratings** |
| **Fixed maturity investments trading, at fair value** | | | | | | | | |
| &nbsp;&nbsp;&nbsp;U.S. treasuries | $10253936 | $— | $10253936 | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;Corporate | 8984951 | 114393 | 312348 | 3618125 | 4005467 | 926109 | 8509 |  |
| &nbsp;&nbsp;&nbsp;Residential mortgage-backed | 2514249 | 148113 | 2238324 | 372 | 3118 | 62374 | 61948 |  |
| &nbsp;&nbsp;&nbsp;Asset-backed | 1629118 | 1145489 | 215976 | 174130 | 84848 |  | 8675 |  |
| &nbsp;&nbsp;&nbsp;Non-U.S. government | 697691 | 434220 | 159861 | 99852 | 2774 | 984 |  |  |
| &nbsp;&nbsp;&nbsp;Agencies | 499011 |  | 498579 |  |  | 432 |  |  |
| &nbsp;&nbsp;&nbsp;Commercial mortgage-backed | 322335 | 270219 | 49820 | 2221 |  |  | 75 |  |
| **Total fixed maturity investments trading, at fair value** | 24901291 | 2112434 | 13728844 | 3894700 | 4096207 | 989899 | 79207 |  |
| **Short term investments, at fair value** | 3883610 | 2642574 | 1231198 | 3863 | 5113 | 601 | 261 |  |
| **Equity investments, at fair value** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed income exchange traded funds <sup>(3)</sup> | 1359777 |  |  | 223951 |  | 1135826 |  |  |
| &nbsp;&nbsp;&nbsp;Common stock and equity exchange traded funds | 234507 |  |  |  |  |  |  | 234507 |
| **Total equity investments, at fair value** | 1594284 |  |  | 223951 |  | 1135826 |  | 234507 |
| **Other investments, at fair value** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Catastrophe bonds | 1609000 |  |  |  |  | 1609000 |  |  |
| &nbsp;&nbsp;&nbsp;Fund investments |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private credit funds | 1465531 |  |  |  |  |  |  | 1465531 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private equity funds | 703805 |  |  |  |  |  |  | 703805 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-strategy funds <sup>(4)</sup> | 543612 |  |  |  |  |  |  | 543612 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance-linked securities funds | 158982 |  |  |  |  |  |  | 158982 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity funds | 45907 |  |  |  |  |  |  | 45907 |
| &nbsp;&nbsp;&nbsp;Direct private equity investments | 124658 |  |  |  |  |  |  | 124658 |
| **Total other investments, at fair value** | 4651495 |  |  |  |  | 1609000 |  | 3042495 |
| **Investments in other ventures, under equity method** | 140853 |  |  |  |  |  |  | 140853 |
| **Total investments** | $35171533 | $4755008 | $14960042 | $4122514 | $4101320 | $3735326 | $79468 | $3417855 |
|  | 100.0% | 13.6% | 42.5% | 11.7% | 11.7% | 10.6% | 0.2% | 9.7% |

---

(1)"Managed" represents the consolidated total investments as presented on the Company's consolidated balance sheets.

(2)The credit ratings included in this table are those assigned by Standard & Poor's Corporation ("S&P"). When ratings provided by S&P were not available, ratings from other recognized rating agencies were used. The Company has grouped short term investments with an A-1+ and A-1 short term issue credit rating as AAA, short term investments with an A-2 short term issue credit rating as AA and short term investments with an A-3 short term issue credit rating as A.

(3)The fixed income exchange traded funds credit ratings included in this table are based on the weighted average credit rating of the underlying investments held by the exchange traded fund.

(4)In the first quarter of 2026, the Company revised the classification of its "fund investments - hedge funds" to be included within "fund investments - multi-strategy funds."

 22

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Investments** | **Investments** | **Investments** | **Investments** | **Investments** | **Investments** | **Investments** | **Investments** | **Investments** |
| **Retained Investments - Credit Rating** <sup>(1)</sup> | **Retained Investments - Credit Rating** <sup>(1)</sup> | **Retained Investments - Credit Rating** <sup>(1)</sup> | **Retained Investments - Credit Rating** <sup>(1)</sup> | **Retained Investments - Credit Rating** <sup>(1)</sup> | **Retained Investments - Credit Rating** <sup>(1)</sup> | **Retained Investments - Credit Rating** <sup>(1)</sup> | **Retained Investments - Credit Rating** <sup>(1)</sup> | **Retained Investments - Credit Rating** <sup>(1)</sup> |
| | | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Credit Rating** <sup>(2)</sup> | **Investments Not Subject to Credit Ratings** |
| **<u>March 31, 2026</u>** | **Fair Value** | **AAA** | **AA** | **A** | **BBB** | **Non-**<br>**Investment**<br>**Grade** | **Not Rated** | **Investments Not Subject to Credit Ratings** |
| **Fixed maturity investments trading, at fair value** | | | | | | | | |
| &nbsp;&nbsp;&nbsp;U.S. treasuries | $7488394 | $— | $7488394 | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;Corporate | 7372851 | 90071 | 270105 | 3051696 | 3292733 | 661201 | 7045 |  |
| &nbsp;&nbsp;&nbsp;Residential mortgage-backed | 2091627 | 123337 | 1840478 | 372 | 3118 | 62374 | 61948 |  |
| &nbsp;&nbsp;&nbsp;Asset-backed | 1489123 | 1062779 | 212144 | 131716 | 74944 |  | 7540 |  |
| &nbsp;&nbsp;&nbsp;Non-U.S. government | 569777 | 353974 | 131276 | 80769 | 2774 | 984 |  |  |
| &nbsp;&nbsp;&nbsp;Agencies | 408399 |  | 408082 |  |  | 317 |  |  |
| &nbsp;&nbsp;&nbsp;Commercial mortgage-backed | 276827 | 240600 | 34839 | 1313 |  |  | 75 |  |
| **Total fixed maturity investments trading, at fair value** | 19696998 | 1870761 | 10385318 | 3265866 | 3373569 | 724876 | 76608 |  |
| **Short term investments, at fair value** | 1191542 | 521588 | 660406 | 3863 | 5051 | 393 | 241 |  |
| **Equity investments, at fair value** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Fixed income exchange traded funds <sup>(3)</sup> | 1293249 |  |  | 223951 |  | 1069298 |  |  |
| &nbsp;&nbsp;Common stock and equity exchange traded funds | 233834 |  |  |  |  |  |  | 233834 |
| **Total equity investments, at fair value** | 1527083 |  |  | 223951 |  | 1069298 |  | 233834 |
| **Other investments, at fair value** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Catastrophe bonds | 288916 |  |  |  |  | 288916 |  |  |
| &nbsp;&nbsp;&nbsp;Fund investments |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private credit funds | 1451199 |  |  |  |  |  |  | 1451199 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private equity funds | 703805 |  |  |  |  |  |  | 703805 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-strategy funds <sup>(4)</sup> | 543612 |  |  |  |  |  |  | 543612 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance-linked securities funds | 158982 |  |  |  |  |  |  | 158982 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity funds | 45907 |  |  |  |  |  |  | 45907 |
| &nbsp;&nbsp;&nbsp;Direct private equity investments | 124658 |  |  |  |  |  |  | 124658 |
| **Total other investments, at fair value** | 3317079 |  |  |  |  | 288916 |  | 3028163 |
| **Investments in other ventures, under equity method** | 140853 |  |  |  |  |  |  | 140853 |
| **Total investments** | $25873555 | $2392349 | $11045724 | $3493680 | $3378620 | $2083483 | $76849 | $3402850 |
|  | 100.0% | 9.1% | 42.7% | 13.5% | 13.1% | 8.1% | 0.3% | 13.2% |

---

(1)"Retained" represents the consolidated total investments, less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. See "Comments on Non-GAAP Financial Measures" for a reconciliation of non-GAAP financial measures.

(2)The credit ratings included in this table are those assigned by Standard & Poor's Corporation ("S&P"). When ratings provided by S&P were not available, ratings from other recognized rating agencies were used. The Company has grouped short term investments with an A-1+ and A-1 short term issue credit rating as AAA, short term investments with an A-2 short term issue credit rating as AA and short term investments with an A-3 short term issue credit rating as A.

(3)The fixed income exchange traded funds credit ratings included in this table are based on the weighted average credit rating of the underlying investments held by the exchange traded fund.

(4)In the first quarter of 2026, the Company revised the classification of its "fund investments - hedge funds" to be included within "fund investments - multi-strategy funds."

 23

------

---

| | | |
|:---|:---|:---|
| **Other Items** | **Other Items** | **Other Items** |
| **Earnings per Share** | **Earnings per Share** | **Earnings per Share** |
| | **Three months ended** | **Three months ended** |
| (common shares in thousands) | **March 31,<br>2026** | **March 31,<br>2025** |
| Numerator: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) available (attributable) to RenaissanceRe common shareholders | $284535 | $161147 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount allocated to participating common shareholders <sup>(1)</sup> | (4572) | (2365) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) allocated to RenaissanceRe common shareholders | $279963 | $158782 |
| Denominator: |  |  |
| &nbsp;&nbsp;&nbsp;Denominator for basic income (loss) per RenaissanceRe common share - weighted average common shares <sup>(2)</sup> | 42434 | 48334 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Per common share equivalents of non-vested shares <sup>(2)</sup> | 194 | 180 |
| &nbsp;&nbsp;&nbsp;Denominator for diluted income (loss) per RenaissanceRe common share - adjusted weighted average common shares and assumed conversions <sup>(2)</sup> | 42628 | 48514 |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - basic | $6.60 | $3.29 |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted | $6.57 | $3.27 |

---

(1)Represents earnings and dividends attributable to holders of unvested shares issued pursuant to the Company's stock compensation plans.

(2)In periods for which the Company has net loss allocated to RenaissanceRe common shareholders, the denominator used in calculating net loss attributable to RenaissanceRe common shareholders per common share - basic is also used in calculating net loss attributable to RenaissanceRe common shareholders per common share - diluted.

 24

------

**Comments on Non-GAAP Financial Measures**

In addition to the GAAP financial measures set forth in this Financial Supplement, the Company has included certain non-GAAP financial measures within the meaning of Regulation G. The Company has provided certain of these financial measures in previous investor communications and the Company's management believes that such measures are important to investors and other interested persons, and that investors and such other persons benefit from having a consistent basis for comparison between quarters and for comparison with other companies within or outside the industry. These measures may not, however, be comparable to similarly titled measures used by companies within or outside of the insurance industry. Investors are cautioned not to place undue reliance on these non-GAAP measures in assessing the Company's overall financial performance.

 25

------

**Comments on Non-GAAP Financial Measures**

**Operating Income (Loss) Available (Attributable) to RenaissanceRe Common Shareholders, Operating Income (Loss) Available (Attributable) to RenaissanceRe Common Shareholders per Common Share – Diluted and Operating Return on Average Common Equity - Annualized**

The Company uses "operating income (loss) available (attributable) to RenaissanceRe common shareholders" as a measure to evaluate the underlying fundamentals of its operations and believes it to be a useful measure of its corporate performance. "Operating income (loss) available (attributable) to RenaissanceRe common shareholders" as used herein differs from "net income (loss) available (attributable) to RenaissanceRe common shareholders," which the Company believes is the most directly comparable GAAP measure, by the exclusion of (1) net realized and unrealized gains and losses on investments, excluding other investments - catastrophe bonds, (2) net foreign exchange gains and losses, (3) expenses or revenues associated with acquisitions, dispositions and impairments, (4) acquisition related purchase accounting adjustments, (5) the Bermuda net deferred tax benefit recorded prior to the January 1, 2025 effective date of the Bermuda corporate income tax and the Bermuda deferred tax benefit resulting from Bermuda law changes enacted in 2025, (6) the income tax expense or benefit associated with these adjustments, and (7) the portion of these adjustments attributable to the Company's redeemable noncontrolling interests. The Company also uses "operating income (loss) available (attributable) to RenaissanceRe common shareholders" to calculate "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted" and "operating return on average common equity - annualized."

The Company's management believes that "operating income (loss) available (attributable) to RenaissanceRe common shareholders," "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted" and "operating return on average common equity - annualized" are useful to management and investors because they provide for better comparability and more accurately measure the Company's results of operations and remove variability. Additionally, management believes that these measures provide a view of the Company's underlying business that allows for better comparisons of the Company's performance over time by focusing on the Company's core business operations.

The following table is a reconciliation of: (1) net income (loss) available (attributable) to RenaissanceRe common shareholders to "operating income (loss) available (attributable) to RenaissanceRe common shareholders"; (2) net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted to "operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted"; and (3) return on average common equity - annualized to "operating return on average common equity - annualized."

 26

------

**Comments on Non-GAAP Financial Measures**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders | $284535 | $161147 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds | 410084 | (373353) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange losses (gains) | 9019 | 7328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses (revenues) associated with acquisitions, dispositions and impairments | 3 | 1436 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related purchase accounting adjustments <sup>(1)</sup> | 22706 | 53571 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bermuda net deferred tax asset <sup>(2)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) <sup>(3)</sup> | (79743) | 39392 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to redeemable noncontrolling interests <sup>(4)</sup> | (56067) | 40725 |
| Operating income (loss) available (attributable) to RenaissanceRe common shareholders | $590537 | $(69754) |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted | $6.57 | $3.27 |
| &nbsp;&nbsp;&nbsp;Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds | 9.62 | (7.70) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange losses (gains) | 0.21 | 0.15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses (revenues) associated with acquisitions, dispositions and impairments |  | 0.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related purchase accounting adjustments <sup>(1)</sup> | 0.53 | 1.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bermuda net deferred tax asset <sup>(2)</sup> |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) <sup>(3)</sup> | (1.86) | 0.81 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to redeemable noncontrolling interests <sup>(4)</sup> | (1.32) | 0.84 |
| Operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted | $13.75 | $(1.49) |
| Return on average common equity - annualized | 10.5% | 6.6% |
| &nbsp;&nbsp;&nbsp;Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds | 15.2% | (15.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net foreign exchange losses (gains) | 0.3% | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses (revenues) associated with acquisitions, dispositions and impairments | —% | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related purchase accounting adjustments <sup>(1)</sup> | 0.8% | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bermuda net deferred tax asset <sup>(2)</sup> | —% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) <sup>(3)</sup> | (2.9)% | 1.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to redeemable noncontrolling interests <sup>(4)</sup> | (2.1)% | 1.7% |
| Operating return on average common equity - annualized | 21.8% | (2.9)% |

---

(1)Represents the purchase accounting adjustments related to the amortization of acquisition related intangible assets, amortization (accretion) of value of business acquired ("VOBA") and acquisition costs, and the fair value adjustments to the net reserves for claims and claim expenses for the three months ended March 31, 2026 for the acquisitions of Validus of $21.0 million (2025 - $50.7 million); and TMR and Platinum of $1.8 million (2025 - $2.9 million).

(2)Represents the net deferred tax benefit related to the 15% Bermuda corporate income tax recorded prior to the January 1, 2025 effective date and the deferred tax benefit related to Bermuda law changes enacted in 2025.

(3)Represents the income tax expense or benefit associated with the adjustments to net income (loss) available (attributable) to RenaissanceRe common shareholders. The income tax impact is estimated by applying the statutory income tax rates of applicable jurisdictions, adjusted for relevant factors and other applicable income taxes.

(4)Represents the portion of the adjustments above that are attributable to the Company's redeemable noncontrolling interests, including the income tax impact of those adjustments.

 27

------

**Comments on Non-GAAP Financial Measures**

**Tangible Book Value Per Common Share and Tangible Book Value Per Common Share Plus Accumulated Dividends**

The Company has included in this Financial Supplement "tangible book value per common share" and "tangible book value per common share plus accumulated dividends." "Tangible book value per common share" is defined as book value per common share excluding per share amounts for (1) acquisition related goodwill and other intangible assets, (2) other goodwill and intangible assets, and (3) acquisition related purchase accounting adjustments. "Tangible book value per common share plus accumulated dividends" is defined as book value per common share excluding per share amounts for (1) acquisition related goodwill and other intangible assets, (2) other goodwill and intangible assets, and (3) acquisition related purchase accounting adjustments, plus accumulated dividends.

The Company's management believes "tangible book value per common share" and "tangible book value per common share plus accumulated dividends" are useful to investors because they provide a more accurate measure of the realizable value of shareholder returns by excluding the impact of goodwill and intangible assets and acquisition related purchase accounting adjustments to provide for better comparability and a more accurate measure of the Company's underlying operations. The following table is a reconciliation of book value per common share to "tangible book value per common share" and "tangible book value per common share plus accumulated dividends."

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Book value per common share | $250.48 | $247.00 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related goodwill and other intangible assets <sup>(1)</sup> | (14.38) | (14.40) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other goodwill and intangible assets <sup>(2)</sup> | (0.20) | (0.21) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related purchase accounting adjustments <sup>(3)</sup> | (2.41) | (2.29) |
| Tangible book value per common share | 233.49 | 230.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for accumulated dividends | 30.09 | 29.68 |
| Tangible book value per common share plus accumulated dividends | $263.58 | $259.78 |
| Year to date change in book value per common share | 1.4% | 26.2% |
| Year to date change in book value per common share plus change in accumulated dividends | 1.6% | 27.0% |
| Year to date change in tangible book value per common share plus change in accumulated dividends | 1.7% | 30.8% |

---

(1)Represents the acquired goodwill and other intangible assets at March 31, 2026 of $617.8 million (December 31, 2025 - $633.1 million) for the acquisitions of Validus of $392.9 million (December 31, 2025 - $408.0 million), TMR of $24.7 million (December 31, 2025 - $25.0 million) and Platinum of $200.1 million (December 31, 2025 - $200.1 million).

(2)At March 31, 2026, the adjustment for other goodwill and intangible assets included $8.9 million (December 31, 2025 - $8.9 million) of goodwill and other intangibles included in investments in other ventures, under equity method.

(3)Represents the purchase accounting adjustments related to the fair value adjustments to reserves at March 31, 2026 for the acquisitions of Validus of $61.9 million (December 31, 2025 - $57.7 million), TMR of $42.2 million (December 31, 2025 - $43.6 million) and Platinum of $(0.5) million (December 31, 2025 - $(0.5) million).

 28

------

**Comments on Non-GAAP Financial Measures**

**Adjusted Combined Ratio**

The Company has included in this Financial Supplement "adjusted combined ratio" for the Company, its reportable segments and certain classes of business. "Adjusted combined ratio" is defined as the combined ratio adjusted for the impact of acquisition related purchase accounting, which includes the amortization of acquisition related intangible assets, purchase accounting adjustments related to the amortization (accretion) of VOBA and acquisition costs, and the fair value adjustments to the net reserve for claims and claim expenses for the acquisitions of Validus, TMR and Platinum. The combined ratio is calculated as the sum of (1) net claims and claim expenses incurred, (2) acquisition expenses, and (3) operational expenses; divided by net premiums earned. The acquisition related purchase accounting adjustments impact net claims and claim expenses incurred and acquisition expenses. The Company's management believes "adjusted combined ratio" is useful to management and investors because it provides for better comparability and more accurately measures the Company's underlying underwriting performance. The following table is a reconciliation of combined ratio to "adjusted combined ratio."

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** |
| | **Catastrophe** | **Other Property** | **Property** | **Casualty and Specialty** | **Total** |
| Combined ratio | 20.4% | 56.8% | 34.1% | 100.4% | 73.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for acquisition related purchase accounting adjustments <sup>(1)</sup> | (1.2)% | (0.7)% | (1.1)% | (1.0)% | (1.0)% |
| Adjusted combined ratio | 19.2% | 56.1% | 33.0% | 99.4% | 72.0% |
|  | **Three months ended December 31, 2025** | **Three months ended December 31, 2025** | **Three months ended December 31, 2025** | **Three months ended December 31, 2025** | **Three months ended December 31, 2025** |
|  | **Catastrophe** | **Other Property** | **Property** | **Casualty and Specialty** | **Total** |
| Combined ratio | (9.3)% | 70.6% | 21.8% | 103.5% | 71.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for acquisition related purchase accounting adjustments <sup>(1)</sup> | (1.7)% | (0.9)% | (1.4)% | (1.2)% | (1.4)% |
| Adjusted combined ratio | (11.0)% | 69.7% | 20.4% | 102.3% | 70.0% |
|  | **Three months ended September 30, 2025** | **Three months ended September 30, 2025** | **Three months ended September 30, 2025** | **Three months ended September 30, 2025** | **Three months ended September 30, 2025** |
|  | **Catastrophe** | **Other Property** | **Property** | **Casualty and Specialty** | **Total** |
| Combined ratio | (6.0)% | 45.0% | 15.5% | 101.4% | 68.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for acquisition related purchase accounting adjustments <sup>(1)</sup> | (1.6)% | (0.8)% | (1.3)% | (2.1)% | (1.8)% |
| Adjusted combined ratio | (7.6)% | 44.2% | 14.2% | 99.3% | 66.6% |
|  | **Three months ended June 30, 2025** | **Three months ended June 30, 2025** | **Three months ended June 30, 2025** | **Three months ended June 30, 2025** | **Three months ended June 30, 2025** |
|  | **Catastrophe** | **Other Property** | **Property** | **Casualty and Specialty** | **Total** |
| Combined ratio | 18.2% | 43.7% | 27.4% | 101.8% | 75.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for acquisition related purchase accounting adjustments <sup>(1)</sup> | (1.8)% | (1.2)% | (1.6)% | (2.3)% | (2.1)% |
| Adjusted combined ratio | 16.4% | 42.5% | 25.8% | 99.5% | 73.0% |
|  | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** |
|  | **Catastrophe** | **Other Property** | **Property** | **Casualty and Specialty** | **Total** |
| Combined ratio | 175.6% | 83.6% | 148.7% | 111.1% | 128.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for acquisition related purchase accounting adjustments <sup>(1)</sup> | (1.6)% | (1.5)% | (1.6)% | (2.3)% | (1.9)% |
| Adjusted combined ratio | 174.0% | 82.1% | 147.1% | 108.8% | 126.4% |

---

(1)Adjustment for acquisition related purchase accounting includes the amortization of the acquisition related intangible assets and purchase accounting adjustments related to the net amortization (accretion) of VOBA and acquisition costs, and the fair value adjustments to the net reserve for claims and claim expenses for the acquisitions of Validus, TMR and Platinum.

 29

------

**Comments on Non-GAAP Financial Measures**

**Retained Total Investment Result**

The Company has included in this Financial Supplement "retained total investment result." "Retained total investment result" is defined as the consolidated total investment result less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. "Retained total investment result" differs from consolidated total investment result, which the Company believes is the most directly comparable GAAP measure, due to the exclusion of the portions of the consolidated total investment result attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. The Company's management believes "retained total investment result" is useful to investors because it provides a measure of the portion of the Company's investment result that impacts net income (loss) available (attributable) to RenaissanceRe common shareholders and provides for a better understanding of the investment risk profile and returns that ultimately affect the Company and influence returns. The following table is a reconciliation of consolidated total investment result to "retained total investment result."

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2026** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** | **Three months ended March 31, 2025** |
| | **Managed** <sup>(1)</sup> | **Adjustment** <sup>(2)</sup> | **Retained** <sup>(3)</sup> | **Managed** <sup>(1)</sup> | **Adjustment** <sup>(2)</sup> | **Retained** <sup>(3)</sup> |
| **Net investment income** | | | | | | |
| &nbsp;&nbsp;&nbsp;Fixed maturity investments trading | $294494 | $(61853) | $232641 | $284723 | $(57895) | $226828 |
| &nbsp;&nbsp;&nbsp;Short term investments | 34306 | (20622) | 13684 | 41029 | (23116) | 17913 |
| &nbsp;&nbsp;&nbsp;Equity investments |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed income exchange traded funds | 21692 |  | 21692 | 1184 |  | 1184 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock <sup>(4)</sup> | 677 |  | 677 | 726 | (4) | 722 |
| &nbsp;&nbsp;&nbsp;Other investments |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Catastrophe bonds | 39932 | (34644) | 5288 | 54754 | (45857) | 8897 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fund and direct private equity investments <sup>(4)</sup> | 25211 | (92) | 25119 | 18723 |  | 18723 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 11163 | (773) | 10390 | 11110 | (840) | 10270 |
|  | 427475 | (117984) | 309491 | 412249 | (127712) | 284537 |
| &nbsp;&nbsp;&nbsp;Investment expenses | (6973) | 1626 | (5347) | (6896) | 1465 | (5431) |
| **Net investment income** | $420502 | $(116358) | $304144 | $405353 | $(126247) | $279106 |
| **Equity in earnings (losses) of other ventures** <sup>(5)</sup> | $20485 | $— | $20485 | $17828 | $— | $17828 |
| **Net realized and unrealized gains (losses) on investments** <sup>(6)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed maturity-related investments <sup>(7)</sup> | $(267948) | $52185 | $(215763) | $312877 | $(38123) | $274754 |
| &nbsp;&nbsp;&nbsp;Equity-related investments <sup>(8)</sup> | (147426) | 1004 | (146422) | (49589) | (127) | (49716) |
| &nbsp;&nbsp;&nbsp;Commodity-related investments <sup>(9)</sup> | 65310 |  | 65310 | 117591 |  | 117591 |
| &nbsp;&nbsp;&nbsp;Other investments |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Catastrophe bonds | (11829) | 11361 | (468) | (40413) | 33622 | (6791) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fund and direct private equity investments <sup>(4)</sup> | (60020) | 609 | (59411) | (7526) |  | (7526) |
| **Net realized and unrealized gains (losses) on investments** | $(421913) | $65159 | $(356754) | $332940 | $(4628) | $328312 |
| **Total investment result** <sup>(5)</sup> | $19074 | $(51199) | $(32125) | $756121 | $(130875) | $625246 |
| **Average invested assets** | $35622372 | $(9707853) | $25914519 | $33116302 | $(9320127) | $23796175 |
| **Net investment income return - annualized** | 4.9% | (0.1)% | 4.8% | 5.1% | (0.3)% | 4.8% |
| **Total investment return - annualized** <sup>(5)</sup> | 0.3% | (0.8)% | (0.5)% | 9.6% | 1.3% | 10.9% |

---

(1)"Managed" represents the consolidated total investment result, which is comprised of net investment income, equity in earnings (losses) of other ventures and net realized and unrealized gains (losses) on investments as presented on the Company's consolidated statements of operations.

(2)Adjustment for the portions of the consolidated total investment result attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds.

(3)"Retained" represents the consolidated total investment result, less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds.

(4)In the fourth quarter of 2025, the Company revised the description of its "other equity investments" to "common stock" and its "other investments - other" to "other investments - fund and direct private equity investments."

(5)In the fourth quarter of 2025, the Company revised its presentation of "total investment result" and "total investment return - annualized" to include equity in earnings (losses) of other ventures. Comparative information for the prior periods presented have been updated to conform to the current presentation.

(6)In the fourth quarter of 2025, the Company revised its presentation of "net realized and unrealized gains (losses) on investments" to show amounts based on net investment exposure, which takes into account related derivative impacts. Comparative information for the prior periods have been updated to conform to the current presentation.

(7)Includes fixed maturity investments and investment-related derivatives, which includes interest rate futures, credit default swaps and interest rate swaps.

(8)Includes equity investments and investment-related derivatives, which includes equity futures and warrants.

(9)Includes commodity-related derivatives, which includes commodity futures and commodity options.

 30

------

**Comments on Non-GAAP Financial Measures**

**Retained Total Investments**

The Company has included in this Financial Supplement "retained total investments." "Retained total investments" is defined as the consolidated total investments, less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. "Retained total investments" differs from consolidated total investments, which the Company believes is the most directly comparable GAAP measure, due to the exclusion of portions of the consolidated total investments attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. The Company's management believes the "retained total investments" is useful to investors because it provides a measure of the portion of the Company's total investments that impacts the investment result included in net income (loss) available (attributable) to RenaissanceRe common shareholders and provides for a better understanding of the investment risk profile and returns that ultimately affect the Company and influence returns. The following table is a reconciliation of consolidated total investments to "retained total investments."

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Managed** <sup>(1)</sup> | **Adjustment** <sup>(2)</sup> | **Retained** <sup>(3)</sup> | **Managed** <sup>(1)</sup> | **Adjustment** <sup>(2)</sup> | **Retained** <sup>(3)</sup> |
| **Fixed maturity investments trading, at fair value** | | | | | | |
| &nbsp;&nbsp;&nbsp;U.S. treasuries | $10253936 | $(2765542) | $7488394 | $10641503 | $(2989769) | $7651734 |
| &nbsp;&nbsp;&nbsp;Corporate | 8984951 | (1612100) | 7372851 | 8528828 | (1874576) | 6654252 |
| &nbsp;&nbsp;&nbsp;Residential mortgage-backed | 2514249 | (422622) | 2091627 | 2606882 | (491472) | 2115410 |
| &nbsp;&nbsp;&nbsp;Asset-backed | 1629118 | (139995) | 1489123 | 1606790 | (130875) | 1475915 |
| &nbsp;&nbsp;&nbsp;Non-U.S. government | 697691 | (127914) | 569777 | 691912 | (142679) | 549233 |
| &nbsp;&nbsp;&nbsp;Agencies | 499011 | (90612) | 408399 | 486817 | (107519) | 379298 |
| &nbsp;&nbsp;&nbsp;Commercial mortgage-backed | 322335 | (45508) | 276827 | 321591 | (54168) | 267423 |
| **Total fixed maturity investments trading, at fair value** | 24901291 | (5204293) | 19696998 | 24884323 | (5791058) | 19093265 |
| **Short term investments, at fair value** | 3883610 | (2692068) | 1191542 | 4759811 | (2927988) | 1831823 |
| **Equity investments, at fair value** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed income exchange traded funds | 1359777 | (66528) | 1293249 | 1582811 |  | 1582811 |
| &nbsp;&nbsp;&nbsp;Equity exchange traded funds | 106569 |  | 106569 |  |  |  |
| &nbsp;&nbsp;Common stock | 127938 | (673) | 127265 | 150179 | (3665) | 146514 |
| **Total equity investments, at fair value** | 1594284 | (67201) | 1527083 | 1732990 | (3665) | 1729325 |
| **Other investments, at fair value** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Catastrophe bonds | 1609000 | (1320084) | 288916 | 1613710 | (1381817) | 231893 |
| &nbsp;&nbsp;&nbsp;Fund investments |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private credit funds | 1465531 | (14332) | 1451199 | 1445158 | (13198) | 1431960 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Private equity funds | 703805 |  | 703805 | 701837 |  | 701837 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-strategy funds <sup>(4)</sup> | 543612 |  | 543612 | 473990 |  | 473990 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance-linked securities funds | 158982 |  | 158982 | 154514 |  | 154514 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity funds | 45907 |  | 45907 |  |  |  |
| &nbsp;&nbsp;&nbsp;Direct private equity investments | 124658 |  | 124658 | 185005 |  | 185005 |
| **Total other investments, at fair value** | 4651495 | (1334416) | 3317079 | 4574214 | (1395015) | 3179199 |
| **Investments in other ventures, under equity method** | 140853 |  | 140853 | 121871 |  | 121871 |
| **Total investments** | $35171533 | $(9297978) | $25873555 | $36073209 | $(10117726) | $25955483 |

---

(1)"Managed" represents the consolidated total investments as presented on the Company's consolidated balance sheets.

(2)Adjustment for the portions of the consolidated total investments attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds.

(3)"Retained" represents the consolidated total investments, less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds.

(4)In the first quarter of 2026, the Company revised the classification of its "fund investments - hedge funds" to be included within "fund investments - multi-strategy funds."

 31

------

&nbsp;&nbsp;&nbsp;**Comments on Non-GAAP Financial Measures**

**Retained Total Investments, Unrealized Gain (Loss)**

The Company has included in this Financial Supplement "retained total investments, unrealized gain (loss)." "Retained total investments, unrealized gain (loss)" is defined as the unrealized gain (loss) of the consolidated total investments, less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. Unrealized gain (loss) of the consolidated total investments is the difference between fair value and amortized cost or equivalent of the respective investments as at the balance sheet date. "Retained total investments, unrealized gain (loss)" differs from the unrealized gain (loss) of the consolidated total investments, which the Company believes is the most directly comparable GAAP measure, due to the exclusion of portions of the consolidated total investments attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. The Company's management believes the "retained total investments, unrealized gain (loss)" is useful to investors because it provides a measure of the portion of the unrealized gain (loss) of investments in the Company's consolidated total investments that is available (attributable) to RenaissanceRe common shareholders and provides for a better understanding of the investment risk profile and returns that ultimately affect the Company and influence returns. The following table is a reconciliation of the total unrealized gain (loss) of investments, to "retained total investments, unrealized gain (loss)."

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Unrealized Gain (Loss) - Managed** <sup>(1)</sup> | **Adjustment** <sup>(2)</sup> | **Unrealized Gain (Loss) - Retained** <sup>(3)</sup> | **Unrealized Gain (Loss) - Managed** <sup>(1)</sup> | **Adjustment** <sup>(2)</sup> | **Unrealized Gain (Loss) - Retained** <sup>(3)</sup> |
| **Fixed maturity investments trading, at fair value** | | | | | | |
| &nbsp;&nbsp;&nbsp;U.S. treasuries | $46066 | $(10357) | $35709 | $134072 | $(32302) | $101770 |
| &nbsp;&nbsp;Corporate | (18441) | (3205) | (21646) | 75453 | (25780) | 49673 |
| &nbsp;&nbsp;Other <sup>(4)</sup> | (19579) | 5834 | (13745) | 16447 | 1690 | 18137 |
| **Total fixed maturity investments trading, at fair value** | 8046 | (7728) | 318 | 225972 | (56392) | 169580 |
| **Short term investments, at fair value** | (4027) | 172 | (3855) | (216) | 206 | (10) |
| **Equity investments, at fair value** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Fixed income exchange traded funds | (25313) | 739 | (24574) | 26827 |  | 26827 |
| &nbsp;&nbsp;&nbsp;Equity exchange traded funds | (8451) |  | (8451) |  |  |  |
| &nbsp;&nbsp;Common stock | 80534 | 86 | 80620 | 95243 | (187) | 95056 |
| **Total equity investments, at fair value** | 46770 | 825 | 47595 | 122070 | (187) | 121883 |
| **Other investments, at fair value** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Catastrophe bonds | 9582 | (9107) | 475 | 25617 | (24172) | 1445 |
| &nbsp;&nbsp;Fund investments | 383870 | 741 | 384611 | 381941 | 259 | 382200 |
| &nbsp;&nbsp;Direct private equity investments | 11265 |  | 11265 | 71612 |  | 71612 |
| **Total other investments, at fair value** | 404717 | (8366) | 396351 | 479170 | (23913) | 455257 |
| **Investments in other ventures, under equity method** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total investments** | $455506 | $(15097) | $440409 | $826996 | $(80286) | $746710 |
| Unrealized gain (loss) on total fixed maturity investments trading, at fair value, per common share <sup>(5)</sup> |  |  | $0.01 |  |  | $3.86 |

---

(1)"Managed" represents the consolidated total investments as presented on the Company's consolidated balance sheets.

(2)Adjustment for the portions of the consolidated total investments attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds.

(3)"Retained" represents the consolidated total investments, less the portions attributable to redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds.

(4)Includes agencies, non-U.S. government, residential mortgage-backed, commercial mortgage-backed and asset-backed securities within the Company's fixed maturity investments trading portfolio.

(5)Represents the impact to book value per common share of the unrealized gain (loss) on total fixed maturity investments trading, at fair value, of $0.3 million at March 31, 2026 (December 31, 2025 - $169.6 million). Book value per common share is calculated net of redeemable noncontrolling interests and third-party investors in various joint ventures and managed funds. Accordingly, there is no corresponding managed metric for the unrealized gain (loss) on total fixed maturity investments trading, at fair value, per common share.

 32

------

&nbsp;&nbsp;**Comments on Non-GAAP Financial Measures**

**Operating (income) loss attributable to redeemable noncontrolling interests**

The Company has included in this Financial Supplement "operating (income) loss attributable to redeemable noncontrolling interests." "Operating (income) loss attributable to redeemable noncontrolling interests" is defined as net (income) loss attributable to redeemable noncontrolling interests as adjusted for the portion of the adjustments to the Company's redeemable noncontrolling interests which are excluded from net income (loss) available (attributable) to RenaissanceRe common shareholders in calculating the Company's operating income (loss) available (attributable) to RenaissanceRe common shareholders. The Company's management believes that "operating (income) loss attributable to redeemable noncontrolling interests" is useful to investors because it provides additional information on the operations and financial results of the Company's Managed Joint Ventures and how noncontrolling interests impact the Company's results. The following table is a reconciliation of net (income) loss attributable to redeemable noncontrolling interests, the most directly comparable GAAP measure, to "operating (income) loss attributable to redeemable noncontrolling interests."

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 31,<br>2026** | **March 31,<br>2025** |
| Net (income) loss attributable to redeemable noncontrolling interests <sup>(1)</sup> | $(222451) | $195252 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for the portion of net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds attributable to redeemable noncontrolling interests | 53490 | (36921) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustment for the portion of net foreign exchange losses (gains) attributable to redeemable noncontrolling interests | 2577 | (3804) |
| Adjustment for non-operating (income) loss attributable to redeemable noncontrolling interests <sup>(2)</sup> | 56067 | (40725) |
| Operating (income) loss attributable to redeemable noncontrolling interests | $(278518) | $235977 |

---

(1)A negative number in the table above represents net income earned by the Consolidated Managed Joint Ventures allocated to third-party investors. Conversely, a positive number represents net losses incurred by the Consolidated Managed Joint Ventures allocated to third-party investors.

(2)Represents the total portion of adjustments attributable to the Company's redeemable noncontrolling interests which are excluded from net income (loss) available (attributable) to RenaissanceRe common shareholders when calculating the Company's operating income (loss) available (attributable) to RenaissanceRe common shareholders. These adjustments include (1) net realized and unrealized gains and losses on investments, excluding other investments - catastrophe bonds and (2) net foreign exchange gains and losses.

 33